Sagen Sie uns Ihre Ziele, gut machen sie unsere. Überlegen Sie sorgfältig die Anlageziele, Risiken, Gebühren und Aufwendungen einer Investmentgesellschaft vor der Anlage. Ein Prospekt enthält diese und andere wichtige Informationen. Kontaktieren Sie uns unter 800-669-3900 für eine Kopie. Lesen Sie sorgfältig, bevor Sie investieren. ETFs können ähnliche Risiken wie Direktbestände, einschließlich Markt-, Branchen - oder Branchenrisiken, mit sich bringen. Einige ETFs können internationale Risiken, Währungsrisiken, Rohstoffrisiken und Zinsänderungsrisiken beinhalten. Die Handelspreise können nicht den Nettoinventarwert der zugrunde liegenden Wertpapiere widerspiegeln. Kommission Gebühren in der Regel gelten. Marktvolatilität, Volumen und Systemverfügbarkeit können den Kontozugriff und die Handelsausführung verzögern. TD Ameritrade lädt keine Plattform-, Wartungs - oder Inaktivitätsgebühren auf. Provisionen, Servicegebühren und Ausnahmegebühren gelten weiterhin. Bitte überprüfen Sie unsere Provisionen und Gebühren für Details. Um Provisionsfreie ETFs zu handeln, müssen Sie im Programm angemeldet sein. Wenn Sie eine berechtigte ETF innerhalb von 30 Tagen nach dem Kauf kommissionell verkaufen, wird eine kurzfristige Handelsgebühr erhoben. Ein Rollover ist nicht Ihre einzige Alternative im Umgang mit alten Altersvorsorgeplänen. Erfahren Sie mehr über Rollover-Alternativen. Der 15-Minuten-Zeitrahmen gilt für normale Situationen und spiegelt möglicherweise nicht die Zeit, die für alle Benutzer erforderlich ist, um alle Offenlegungsdokumente zu lesen, die durchgeführt werden sollten. Die Kontofinanzierung muss abgeschlossen sein, damit der Handel beginnen kann. Angebot gültig für eine neue Person, Joint oder IRA TD Ameritrade Konto eröffnet von 03312017 und finanziert innerhalb von 60 Kalendertagen Kontoeröffnung mit 3.000 oder mehr. Um 100 Bonus zu erhalten, muss das Konto mit 25.000-99.999 finanziert werden. Um 300 Bonus zu erhalten, muss das Konto mit 100.000-249.999 finanziert werden. Um 600 Bonus zu erhalten, muss das Konto mit 250.000 oder mehr finanziert werden. Das Angebot gilt nicht für steuerfreie Trusts, 401k Accounts, Keogh Pläne, Profit Sharing Plan oder Money Purchase Plan. Das Angebot ist nicht übertragbar und nicht gültig mit internen Überweisungen, TD Ameritrade Institutional Accounts, von TD Ameritrade Investment Management verwalteten Konten, aktuellen TD Ameritrade-Konten oder anderen Angeboten. Qualifizierte Provisionsfreies Internet-Aktien, ETF - oder Optionsaufträge sind auf maximal 500 begrenzt und müssen innerhalb von 60 Kalendertagen nach Rechnungslegung erfolgen. Vertrags-, Ausübungs - und Abtretungsgebühren gelten weiterhin. Beschränken Sie ein Angebot pro Client. Der Kontobetrag des qualifizierten Kontos muss 12 Monate oder, wenn TD Ameritrade das Konto berechnen darf, gleich dem Wert nach dem Nettobetrag (abzüglich etwaiger Verluste aus Handels - oder Marktvolatilität oder Margin Debit-Salden) gleich oder größer sein Die Kosten des Angebots nach eigenem Ermessen. TD Ameritrade behält sich das Recht vor, dieses Angebot jederzeit einzuschränken oder zu widerrufen. Dies ist kein Angebot oder eine Aufforderung in einem Land, in dem wir nicht berechtigt sind, Geschäfte zu tätigen. Bitte erlauben Sie 3-5 Werktage für jede Bareinlagen auf Konto zu buchen. Steuern im Zusammenhang mit TD Ameritrade-Angebote sind in Ihrer Verantwortung. Retail-Werte von 600 oder mehr während des Kalenderjahres werden in Ihrem konsolidierten Formular 1099 enthalten sein. Bitte konsultieren Sie einen gesetzlichen oder Steuerberater für die letzten Änderungen in der US-Steuer-Code und für Rollover-Förderfähigkeit Regeln. (Angebotscode: 220). Brokerage-Dienstleistungen von TD Ameritrade, Inc. Mitglied FINRA SIPC. Dies ist kein Angebot oder eine Aufforderung für Maklerdienstleistungen, Anlageberatung oder andere Produkte oder Dienstleistungen in einer Gerichtsbarkeit, in der wir nicht berechtigt sind, Geschäfte zu tätigen, oder wenn ein solches Angebot oder eine solche Aufforderung den Wertpapiergesetzen oder anderen lokalen Gesetzen und Verordnungen zuwiderläuft Einschließlich, aber nicht beschränkt auf Personen mit Wohnsitz in Australien, Österreich, Frankreich, Deutschland, Hongkong, Italien, Japan, den Niederlanden, Saudi-Arabien und Singapur. TD Ameritrade ist ein eingetragenes Warenzeichen der TD Ameritrade IP Company, Inc. und der Toronto-Dominion Bank. Kopie 2017 TD Ameritrade. Diese Website ist nicht für Einwohner von Großbritannien oder Kanada gedacht. Die britischen und kanadischen Einwohner müssen TD Waterhouse besuchen. 16: 48 Uhr Veeco Instruments-Preise erhöhen den Börsengang von 300 Mio. EUR (von 200 Mio. EUR) auf 2,70 Wandelanleihen im Wert von 2023 mit einem Nettoerlös von ca. 291,5 Mio. EUR (VECO). Die Schuldverschreibungen sind vorrangige unbesicherte Verbindlichkeiten von Veeco und Zinsen werden halbjährlich zu einem Satz von 2,70 pro Jahr gezahlt. Der ursprüngliche Wandlungssatz der Schuldverschreibungen beträgt 24.9800 Stammaktien je 1.000 Hauptsumme der Schuldverschreibungen (was einem anfänglichen Wandlungspreis von 18.38 Uhr entspricht.) Broadcom-Preise kündigten bereits ein Angebot von 2,75 Mrd. 2,375 Sr Schuldverschreibungen 2020, 3,5 an Bln von 3.000 Sr Notes fällig 2022, 2.5 bln von 3.625 Sr Notes fällig 2024 und 4.8 bln von 3.875 Sr Notes fällig 2027 (AVGO).Die Schließung des Angebots wird voraussichtlich am 19. Januar 2017 erfolgen. 18:18 Uhr Starpharma gewährt Qualifizierte Infektionskrankheit Produkt-und Fast-Track-Bezeichnung für VivaGel BV von der FDA (SPHRY ).Die Patientenregistrierung in der wiederkehrenden BV-Programm wurde im Oktober 2016 abgeschlossen, und die Studien werden voraussichtlich im Q1 des CY2017, mit Top-Line-Ergebnisse im Q2 erwartet abzuschließen 5:51 PM B. Riley finanziert große amerikanische Kapitalpartner, um 20 mln älteren gesicherten Begriffdarlehen zu den Luxusgütern coMPANY ELEVEN JAMES (RILY) zur Verfügung zu stellen 5:49 PM Southern Missouri Bancorp wird TammcORP IN EINEM STOCK UND CASH TRANSACTION (SMBC) : Southern Missouri Bancorp und Tammcorp, die 91 Eigentümer der Capaha Bank, kündigte die Unterzeichnung einer endgültigen Fusionsvereinbarung, wobei Southern Missouri Tammcorp in einer Aktie und Cash-Transaktion zu erwerben. Die Minderheitsgesellschafter von Capaha sind auch berechtigt, die im Rahmen des Fusionsvertrages zu zahlende Fusionskontrolle zu erhalten. Am 30. September 2016 betrug Tammcorps konsolidierte Vermögenswerte 193,8 Millionen und Southern Missouri meldete die Bilanzsumme am 30. September 2016 von 1,5 Milliarden. Auf Pro-forma-Basis wird nach der Akquisition die Gesamtbilanzsumme 1,7 Mrd., die Gesamtdarlehen netto 1,4 Mrd. und die Gesamtbilanzsumme 1,3 Mrd. betragen. Vorbehaltlich der Anpassung des Tammcorp-Kapitals am Abschluss und der Annahme, dass alle Minderheitsgesellschafter der Capaha vor dem Abschluss ihr Interesse an Capaha für Tammcorp-Aktien tauschen, wird der Deal auf rund 23,4 Mio. US-Dollar geschätzt. Unter den Bedingungen der Fusionsvereinbarung, die einstimmig von den Boards genehmigt wurde Der beiden Gesellschaften, erhalten Tammcorp Aktionäre Southern Missouri Stammaktien für die Hälfte der Fusionskontrolle und Cash für die andere Hälfte. Die Anzahl der auszugebenden Southern-Missouri-Aktien wird auf der Grundlage des auf den NASDAQ-Börsenkurs notierten durchschnittlichen Schlusskurses von Southern Missouris während der 20 Börsentage, die am fünften Handelstag vor dem Abschlussdatum enden, bestimmt. Als Teil der Fusion wird Southern Missouri auch davon ausgehen, ca. 3,8 Millionen in Schulden. 17:46 Die Team-Health-Holdings-Aktionäre genehmigen 43,50 pro SARAR-AKQUISITION VON MIT BLACKSTONE VERBUNDENEN FONDS (BX) ERWARTET DAS TRANSAKTION IM 1. QUARTAL im Jahr 2017 (TMH). 5:39 pm Entree GolD SCHLIEßT DIE ERSTE TRANCHE DER FINANZIERUNGSVERFAHREN ZUR VERBRAUCHUNG ZUR UNTERSTÜTZUNG DER RESTRUKTURIERUNG (EGI). Die Gesellschaft hat 17,309,971 Einheiten zu einem Preis von C0,41 pro Einheit für Bruttoerlöse von C7,097,088 ausgegeben. Eine zweite Tranche von 1.219.513 Einheiten wird voraussichtlich am oder um den 16. Januar 2017 geschlossen. Die Gesellschaft wird einen wesentlichen Änderungsbericht im Zusammenhang mit der Transaktion weniger als 21 Tage vor dem erwarteten Zeitpunkt des Abschlusses der Transaktion einreichen Kürzere Frist aufgrund der Art der Transaktion und der Tatsache, dass alle erforderlichen Genehmigungen erteilt worden sind. 5:18 PM TIMMINS GOLDBERICHTE Q4 VORLÄUFIGE PRODUKTIONSERGEBNISSE - ERHÖHTE HERSTELLUNG VON 25.287 GOLD OUNCES (TGD). Der Bergbau in der Mine von San Francisco verläuft nach dem Minenplan weiter. Guidance für 2017 ist zwischen 70.000 und 75.000 Goldunzen bei Cash-Kosten von US900 auf US950 pro Goldunze. Erwarten Sie im ersten Quartal die Produktion von 20.000 Unzen, trug zu 15.000 Unzen im dritten Quartal dann Rückkehr in die 20.000 Unzen Bereich für Q4. Wie in dem kürzlich veröffentlichten technischen Bericht von San Francisco erwähnt wird, wird erwartet, dass der Bergbau in San Francisco bis 2023 fortgesetzt wird und 450.000 bis 500.000 Unzen Gold zu Bargeldkosten von US900 bis US950 pro Unze (einschließlich 2016) produziert. Ana Paula: Vorbauarbeiten an Ana Paula verlaufen planmäßig. Die Machbarkeitsstudie Testwork geht wie geplant voran und das 20.000 Meter lange Bohrprogramm steht kurz vor der Fertigstellung. Die Co erwartet, dass die Machbarkeitsstudie bis Mitte 2017 abgeschlossen ist, mit Baugenehmigungen, die am Ende des Jahres erhalten wurden. 5:14 PM UR-ENERGY BIETET Q4 OPERATIVE ERGEBNISSE UND DISCUSSES 2017 GUIDANCE (URG). Lost Creek Uranium SalesHighlights: Für das Quartal wurden 103.558 Pfund U3O8 innerhalb der Lost Creek-Anlage gefangen. 111.049 Pfund U3O8 wurden in Trommeln verpackt und 98.775 Pfund U3O8 des drummed Inventars wurden von der Lost Creek-Verarbeitungsanlage zum Konverter geliefert. Die Produktion wurde auf niedrigeren Niveaus kontrolliert, da der Markt deprimiert blieb und die Vertragsverpflichtungen weitgehend im Jahr zuvor erfüllt wurden. Am 31. Dezember lag das Inventar bei der Umwandlungsanlage bei etwa 84,689 Pfund U3O8. Der Auftragsumsatz für das Quartal von Lost Creek-produzierten U3O8 betrug 100.000 Pfund zu einem durchschnittlichen Preis von 32,70 pro Pfund, für einen Umsatz von 3,3 Mio.. Aufgrund des anhaltend tiefen Spotumfeldes wurden im Berichtsquartal keine Spot-Verkäufe erzielt. Die Kooranzierung von 2,6 Mio. in aufgeschobenen Umsätzen aus der ersten Hälfte des Auftragsgeschäfts im Jahr 2016 Q3. Die Co wird im Jahr 2016 Q4 zusätzliche 2,5 Millionen an abgegrenzten Einnahmen aus 2H des Zuweisungstransfers erkennen. Ohne die Abtretung der Transaktion, verkaufte die Co verkauft 562.000 Pfund U3O8 aus Lost Creek Produktion zu einem durchschnittlichen Preis von 39,49 pro Pfund. Permating Update: Der Sole-Stream wird auch weiterhin in der UIC Klasse I tiefen Brunnen entsorgt werden, während der saubere, durchdringende Strom wird In die UIC-Klasse-V-Wells injiziert werden. Es wird erwartet, dass diese betrieblichen Abläufe, die derzeit in Betrieb genommen werden, die Abwasserentsorgungskapazitäten am Standort erheblich erhöhen und die Wellfield-Durchflussraten erhöhen werden. Guidance für 2017: Wie bereits erwähnt, hat co im Jahr 2017 vertraglich 600.000 Pfund begangen, Zu einem durchschnittlichen Preis von 51 pro Pfund. Co wird zum Zeitpunkt der Einreichung des Jahresberichts auf Formular 10-K weitere Informationen geben, die derzeit am Freitag, den 3. März 2017 eingereicht werden sollen. 17:10 Uhr Silver STANDARD BIETET 2016 PRODUKTION - ALLE DREI BETRIEBE MET ODER ÜBERSTÖRT VERBESSERTE LEITFADEN 2017 PRODUCTION GUIDANCE (SSRI). Viertes Quartal und 2016 Operative Highlights: Konsequente Erfolgsbilanz: Bereits zum fünften Mal in Folge wurde die Produktionsberatung erreicht. Rekordjahresproduktion: Produziert 393.325 Goldäquivalent Unzen im Jahr 2016 als alle drei Operationen erfüllt oder überschritten zuvor verbesserte Produktions-Orientierung. Im vierten Quartal belief sich die Goldäquivalentproduktion auf 110.130 Unzen. Robuste Goldproduktion bei Marigold: Die Produktion im vierten Quartal war mit 59.945 Unzen Gold am stärksten, was die Gesamtjahresproduktion auf 205.116 Unzen betrug. Überdurchschnittliche Goldproduktionsberatung bei Seabee: Die Mine erzielte die höchste Jahresproduktion in ihrer 26-jährigen Firmengeschichte und produzierte im Jahr 2016 77.640 Unzen Gold. Mit einer Produktion im vierten Quartal von 19.711 Unzen Gold übertraf die Produktion im zweiten Halbjahr unser H2 2016 Produktionsführungsprogramm. Rekordjahres-Silberproduktion bei Pirquitas: Die Mine schloss ein erfolgreiches Jahr mit der vierten Quartalproduktion von 2,2 Millionen Unzen Silber ab, wobei die jährliche Produktion auf einen Rekordwert von 10,4 Millionen Unzen Silber im Jahr 2016 2017 Outlook: Im Jahr 2017 auf einer konsolidierten Basis an der Mitte Der Anleitung, Silver Standard erwartet, um 355.000 Goldäquivalent Unzen zu Goldäquivalent Cash-Kosten von 735 pro Unze produzieren. Cash-Kosten und Kapitalführung basieren auf 55 pro Barrel Ölpreis und 1,30 kanadischen US-Dollar-Wechselkurs. Goldäquivalente Zahlen basieren auf einem Preis von 1.250 pro Unzen Gold und einem Preis von 17,50 pro Unze Silber. Die Ringelblumenproduktion wird voraussichtlich im Vergleich zu 2016 ansteigen, da die Mine von den auf den Laugenflächen gestapelten Goldunzen über die letzten Monate 2016 und von der anhaltend starken Leistung im Jahr 2017 profitiert. Damit wird die Produktion im ersten Halbjahr gewichtet des Jahres. Bei der Seabee-Gold-Operation wird 2017 unser erstes volles Jahr des Eigentums mit der Produktion in der Nähe Rekordhöhen zwischen 72.000 und 82.000 Unzen Gold bei niedrigen Cash-Kosten, basierend auf Mill-Durchsatz von 900 Tonnen pro Tag zu bleiben. Die jährliche Produktion wird voraussichtlich in der zweiten Jahreshälfte gewichtet werden, da die Minenqualität voraussichtlich noch steigen wird, wenn im Santoy-Minenkomplex bis Anfang 2017 zusätzliche Ebenen entwickelt werden. Wir bewerten weiterhin unser Recht, unsere Option zur Gründung eines Joint Ventures auszuüben Auf dem Chinchillas-Projekt als eine Gelegenheit, das Bergwerk Leben auf Pirquitas. quot 4:59 pm erweitern Berkshire Hathaways Richline Group erworben Schmuck-Hersteller und Vermarkter Die Aaron-Gruppe wirksam heute (BRK. A). 4:57 PM BABCOCK amp WILCOX UNTERNEHMEN UNIVERSAL AKUSTISCHER AMP EMISSIONSTECHNOLOGIEN, DIE IM JAHRE 2017 (BW) AKTIV WERDEN KÖNNEN. UniversalAET ist eine Bolt-on-Akquisition für BampW MEGTEC und wird in das operative Segment BampWs Industrial aufgenommen. Das neue Unternehmen heißt Babcock amp Wilcox Universal und firmiert unter dem Markennamen BampW Universal. Das Geschäft basiert auf einem Unternehmenswert von 55 Millionen, vorbehaltlich bestimmter Anpassungen. UniversalAET wird voraussichtlich im Jahr 2017 rund 80 Millionen jährlicher RENOVIERUNG UND AKKRETISCHER BESCHEINIGUNG produzieren. 16:52 ORCHID ISLAND CAPITAL BERICHTE GESCHÄTZTES BUCH VALUE PRO SHARE AM 31. DEZEMBER 2016 VON 10.09 VS 11.21 AM SEPTEMBER-END (ORC). 4:44 pm Kosmos EneRGy gibt bekannt, dass die mit WARBURG PINCUS und BLACKSTONE (BX) assoziierten Gesellschaften vereinbart haben, 30 Mio. Stammaktien in einem eingetragenen, unterzeichneten PUBLIC OFFERING (KOS) zu verkaufen. 4:35 pm Callaway Golf zu Gastgeber einer Telefonkonferenz zur Akquisition von OGIO International diskutieren TOMORROW JANUAR 12 um 2:00 P. M. PST (ELY). 4:35 pm NASDAQ Berichte Volumen, Marktanteil und Umsatzerfassung für Dezember2016 Dezember US-Matched Equity-Volumen fiel 13 (NDAQ). Bericht. 4:32 pm Northern Dynasty Minerals kündigt 25-Millionen-Buy-Deal-Syndikats vereinbart, zu erwerben 13,52 MLN GEMEINSAME AKTIEN AM 1.85 ANGEBOTENER AKTIE (NAK). 4:24 pm Marathon Petroleum: John Fox, Mitbegründer von MarkWest Kohlenwasserstoff, eröffnet offenen Brief an den Vorstand von MPC Gegen den vorgeschlagenen 3. Januar 2017 Plan und bietet neuen Plan (MPC): Highlights des Briefes (wie von John Fox): Das beschleunigte Dropdown der Raffinerievermögen schadet dem langfristigen MPC-Wert und vermindert die Wachstumsperspektiven bei MPLX, was zu erhöhten Kapitalkosten führt. MPC muss den IDR-Eliminierungsplan sofort zu einem fairen und transparenten Preis ohne Belastung des MPC auf 1,4 Milliarden ausführen In jährlichen Zahlungen an MPLX von Dropdown-Vermögenswerte, die nicht passen das Wachstumsprofil und sind strategisch für MPC Raffinerie business. Process durch Spinnen aus MPCs derzeitigen Besitz von 87 Millionen MPLX-Einheiten, plus die MPLX-Einheiten aus dem IDR Beseitigung zu seinen Aktionären erhalten wird eine Geschätzte sofortige Erhöhung des Wertes für MPC-Aktionäre zwischen 20-30 pro Aktie. 4:21 pm Closing Market Zusammenfassung: Börse schließt Mittwoch bescheiden höher (: WRAPX): Die wichtigsten Durchschnitte geschlossen Mittwochs Sitzung im Grün mit dem SampP 500 Zugabe von 0,3. Der Dow übertraf den Benchmark-Index mit einem Gewinn von 0,5. Die Börse hielt einen bescheidenen Gewinn, der zur Präsidentenwahl Trumpf erste Nachrichtenkonferenz seit dem Gewinn der Präsidentenwahl gehend. Allerdings gab der Markt zurück alle seine Gewinne und mehr, nachdem Herr Trump den Wunsch, die pharmazeutischen Operationen in die Vereinigten Staaten zurückbringt und stimmten Unterstützung für wettbewerbsfähige Droge Preis bieten. Die Biotechnologie-Industrie stürzte sofort, mit der iShares Nasdaq Biotechnologie ETF (IBB 278.04, -8.31), die um 3,0 abschließt. Die meisten Sektoren kehrten nach oder über ihre Vorkonferenzniveaus am Nachmittag zurück, aber Gesundheitspflege (-1.0) konnte nicht biotechnologys überwältigender beträchtlicher Schlag. Investoren in der Hoffnung, über President-elects Infrastruktur-Ausgaben Pläne zu hören kam weg mit leeren Händen. Telekom-Dienstleistungen (-0,5) und Immobilien (-0,5) auch in negativen Bereich fertig, während die restlichen acht Räume in den grünen geschlossen. Energie (1.2) übertraf die Tage Leaderboard, Huckepack auf Rohöl klettern. Die Ware bewegte sich um 2,7 bei 52,20 Bb. Inmitten der Berichte, dass Saudi-Arabien, der weltweit Top-Exporteur, plant, die Versorgung nach Asien zu senken. Crude erweiterte seinen Gewinn trotz einer großen Bestandsaufnahme, die durch die neuesten Lagerbestände Daten enthüllt wurde. Auch der nach oben gewichtete Technologieraum (0,7) beendete nach einem Nachmittagsschub von einigen seiner Top-Komponenten auch den Spitzenplatz. So entwickelten sich beispielsweise Apple (AAPL 119.75, 0.64), Facebook (FB 126.09, 1.74) und IBM (IBM 167.75, 2.23) zwischen 0,6 und 2,2. Chipmakers auch einen Schub als der PHLX Halbleiter Index schloss 0.4. Financials (0,5) gelöscht ihre wöchentlichen Verlust, der mittwochs Sitzung durchgeführt wurde. Der Sektor sammelte zu einer Sitzung hoch während des Spätnachmittags Tätigkeit. Zyklische Sektoren haben eine führende Führung für die Woche, da fünf der sechs in positives Gebiet sind. Materialien und Technologie setzen das Tempo mit wöchentlichen Gewinnen von 0,9 bzw. 0,7. Umgekehrt veröffentlichen alle fünf defensiven Sektoren wöchentliche Verluste mit Immobilien (-2,4), die den Rückzug führen. US-Treasuries beendete den Handelstag bescheiden höher nach dem Treasurys 20 Milliarden 10-jährige Wiedereröffnung Auktion zog eine hohe Ausbeute von 2,342 auf einem Bid-to-Cover von 2,58 x. Die 10-yr-Ausbeute schloss um einen Basispunkt niedriger bei 2,37. Mittwochs einsamer Wirtschaftsbericht wurde der MBA Mortgage Index, die 5.8 erhöht. Die volkswirtschaftlichen Daten von Tomorrow umfassen Dezember ImportExport Preise und Anfangsansprüche (Briefing Consensus 235k) um 8:30 Uhr ET, gefolgt von der Schatzkammer um 14:00 Uhr ET. Russell 2000 1.2 YTD Dow Jones Industrial Average 1,0 YTD SampP 500 1.6 YTDNASDAQ COMPOSITE 3.4 YTD 16.20 Callaway Golf ERWIRBT OGIO INTERNATIONAL FÜR 75,5 MLN in einer All-Cash-Transaktion Callaways MANAGEMENT dass sich die Akquisition sofort steigernd ERGEBNIS (ELY). Callaway-Projekte Das erworbene Unternehmen wird nach der Integration der Akquisition ein jährliches EBITDA von rund 10 Millionen Euro generieren und die meisten operativen Synergien realisieren. Callaway schätzt, dass der Großteil der operativen Synergien innerhalb von zwei Jahren realisiert wird. Der Kaufpreis bewertet OGIO mit einem Vielfachen von ca. 7,6x prognostiziertem EBITDA. Callaway erwartet auch, einen signifikanten Wert aus potenziellen steuerlichen Vorteile mit der Transaktion verbunden zu realisieren. 2017 wird OGIO erwartet, dass zu Callaway etwa 45 Millionen Umsatz beitragen. Nach Aufnahme nicht wiederkehrende Transaktion und Transformationskosten von rund 7 Millionen wird OGIO erwartet um etwa 0,02 bis Callaways 2017 ERGEBNIS JE AKTIE Verwässerungs zu sein, ist aber nicht zu erwarten steigernd THEREAFTER. CALLAWAY BEABSICHTIGT die Transaktion mit Bargeld zu finanzieren und DARLEHEN VON SEINE BESTEHENDEN ASSET-BACKED CREDIT-MÖGLICHKEITEN. 4:20 PM HORIZON TECHNOLOGY FINANZIERT Q4 PORTFOLIO-AKTUALISIERUNG (HRZN): quotUnsere vierten Quartalstätigkeit beinhaltete neue Kredite an zwei Unternehmen der öffentlichen Lebenswirtschaft und positive Liquiditätsereignisse von drei Portfolio-Unternehmen, die unsere Liquiditätsposition verbessert haben, so Gerald A. Michaud, Präsident von Horizon. Während dieser Zeit haben wir auch wichtige Schritte unternommen, um unsere Investitionsplattform zu stärken, indem wir unseren Senior Life Sciences-Teams zwei Senioren-Mitarbeiter engagieren. Mit unseren erweiterten Kapazitäten und unserer starken Liquidität haben wir unsere Position im Jahr 2017 hervorragend positioniert. Horizon hat im vierten Quartal 2016 zwei neue Kredite in Höhe von 13,8 Mio. Euro und 13 neue Kredite in Höhe von 57,8 Mio. Euro für das Jahr finanziert. Im Laufe des Quartals zum 31. Dezember 2016 schloss Horizon gegenüber dem am 30. September 2016 endenden Quartal neue Darlehenszusagen in Höhe von insgesamt 27,5 Millionen Euro ab, wobei Horizon neue Darlehenszusagen in Höhe von insgesamt 17,0 Millionen an zwei Gesellschaften schloss , Horizons unfunded Darlehen Genehmigungen und Verpflichtungen, die alle zu schwimmenden Zinsen Preisen waren 20,8 Millionen an vier Unternehmen. Dies steht im Vergleich zu einem Committed Backlog von 19,5 Millionen auf drei Unternehmen zum 30. September 2016. Während Horizons Portfolio-Unternehmen Ermessen, ob eine solche ENGAGEMENT nach unten zu ziehen, zu sein Engagement für das Recht eines PORTFOLIO UNTERNEHMEN ZIEHEN NACH UNTEN IST Erreichen bestimmter OFT SUBJECT MEILENSTEINE UND ANDERE VORAUSSETZUNGEN. 4:19 PM HFF INC. SECURES 162 MLN IN FINANZIERUNG FÜR EIN 13-GEBÄUDE INDUSTRIELLE PORTFOLIO-SUMME 2.67 MLN SQUARE FÜSSE IN NORDEN NEW JERSEY (HF). 4:17 pm Mercury kündigte an, dass es vor kurzem 6,9 MLN IN BEZUG AUF EINEN SENSORVERARBEITUNGSANTRAG FÜR FIGHTER AIRCRAFT DURCHGEFÜHRTE AUFTRÄGE IM COS FISCAL 2017 SECOND QUARTER (MRCY) erhalten hat. 4:16 pm Artisan Partners Asset Mgmt berichtet, dass die verwalteten Vermögen zum 31. Dezember 96,8 Milliarden gegenüber 97,2 Milliarden Ende November (APAM) betrugen. 4:16 pm Invesco Berichte 31. Dezember 2016 AUM 0,9 mm bis 812,9 bln (IVZ). 4:16 pm Derma Sciences erwirbt die Marke MEDIHONEY und damit verbundenes geistiges Eigentum und Goodwill von Comvita für eine Vorauszahlung von 13,25 Millionen in bar, w zusätzlich 5,0 Millionen potenziell zahlbar (DSCI). Betrachtung ist eine Vorauszahlung von 13,25 Millionen in bar, mit einem zusätzlichen 5,0 Millionen potenziell zahlbar in Form eines Earn-out bei der Erreichung der künftigen jährlichen Umsatz Meilensteine. Vor der Akquisition hielt Derma Sciences die exklusive globale Lizenz für die Marke MEDIHONEY von Comvita und Patente für die medizinischen und professionellen Marktsegmente. Der Kauf eliminiert die Verpflichtung von Derma Sciences, Lizenzgebühren an Comvita beim Verkauf von MEDIHONEY-Produkten zu zahlen. Diese Lizenzgebühren beliefen sich im Jahr 2016 auf 1,6 Millionen. Zusätzliche Vereinbarungen, die zum Zeitpunkt der Akquisition abgeschlossen wurden, beinhalten eine exklusive medizinische Honiglieferungsvereinbarung von Comvita an Derma Sciences for 10 Jahre bei fixpreis~~POS=TRUNC BEDINGUNGEN FÜR ZWEI JAHRE, ein weltweit LIZENZVEREINBARUNG VON DERMA SCIENCES zU COMVITA, die erworbenen Schutz geistigen Eigentums und den OTC-Markt ergeben, und die kontinuierliche Herstellen von Honigbasis PRODUKTE VON DERMA SCIENCES FÜR COMVITA FÜR OTC CONSUMER PRODUCT SALES. 4:16 PM VEREIT BERICHTE Q4 ENTSORGUNG UND AKQUISITION AKTIVITÄT VERKAUFT 394,9 MILLIONEN DER VERMÖGENSWERTE UND KAUFEN 80,2 MILLIONEN DER VERMÖGENSWERTE (VER). 4:16 pm Antero Midstream Partners erhöht die Quartalsverteilung auf 0,28 Units von 0,2650 Units (AM). 4:13 pm KB Home misses von 0,04 (: GAAP), schlägt auf revs, wie Bestellungen beschleunigen (KBH). Berichte Q4 (Nov) GAAP-Ergebnis von 0,40 pro Aktie (einschließlich 0,06 Aktien in Vorsteuer-Inventar Gebühren), 0,04 schlimmer als der Capital IQ Consensus von 0,44 Umsatz stieg um 20,9 Jahre bis 1,19 Milliarden vs der 1,14 Milliarden Capital IQ Consensus. Die Netto-Auftragseingänge für das Quartal stiegen von 20 auf 2.254 (v. 16 in Q3) und der Nettoauftragswert stieg um 27 auf 855,9 Mio. Der Auftragsbestand zum 30. November 2016 stieg um 11 auf 4.420. Der Rückstandswert wurde um 19 auf 1,52 Milliarden gesteigert, mit zweistelligen Zuwächsen in drei der vier Unternehmen. Die Lieferungen wuchsen 19 bis 3.060 Wohnungen, wobei in jedem der vier Unternehmen des Unternehmens eine Zunahme zu verzeichnen war. Der durchschnittliche Verkaufspreis erhöhte sich auf 2 bis 387.400. Housing Bruttogewinnspanne sank um 70 Basispunkte auf 16,5. Bereinigte Gehäuse Bruttogewinn-Marge, eine Metrik, die die Abschreibung von zuvor kapitalisierten Zinsen und Lagerbeeinträchtigungen und Flächenoption Kontraktabbruchgebühren von 5,5 Millionen ausschließt, sank 60 Basispunkte auf 21,6. Der Buchwert je Aktie erhöhte sich um 11 auf 20,25. "Mit einer gesunden Netto-Auftragsaktivität im vierten Quartal, die zu unserem höchsten Rückstandswert in 10 Jahren beiträgt, gehen wir 2017 mit einer starken Dynamik ein, sagte Mezger. "Unsere Strategie ist es, den Umfang unseres Geschäfts in unserem aktuellen geografischen Fußabdruck weiter auszubauen, unsere operativen Gewinne zu steigern und gemeinsam mit unseren Mitarbeitern unser zukünftiges Wachstum zu fördern und unsere Wachstumsrate zu steigern. Wir glauben, wir sind gut an Kapital schlagen den anhaltenden Anstieg der Nachfrage aus Erstkäufer BEGLEIT aktuellen positiven wirtschaftlichen und demographischen Entwicklungen in vielen unserer GEDIENTE MARKETS. quot 04.09 AUFGE ACMBernstein kündigt 31. Dezember 2016 AUM BLN bis 480 ERHÖHT, A 0,4 INCREASE VS. DIE 478 BLN AM ENDE DES LETZTEN MONATS (AB). 16:07 Stratus Properties schließt mit Oasis Management eine Vereinbarung ab, nach der Ella Gendel sofort in den Vorstand berufen wurde (STRS). 16:06 Uhr NASDAQ berichtet am Ende des Monats offene Short Interest Positionen in Nasdaq Stocks ab dem Settlement Date 30. Dezember (NDAQ). Zusammengefasst betrug kurz Interesse an allen 3.131 Nasdaq Wertpapiere 7800241383 Aktien zum 30. Dezember 2016 FÄLLIGKEIT, IM VERGLEICH ZU 3142 FRAGEN UND 7918892163 AKTIEN AM ENDE DES vorherigen Periode. DIESES IST 3.92 TAGE DURCHSCHNITTLICH TÄGLICH VOLUMEN, VERGLEICH MIT EINEM DURCHSCHNITT VON 4.33 TAGEN FÜR DEN VORJAHRESBERICHT ZEITRAUM. 16.06 HISTOGENICS KÜNDIGT eine Online-Publikation im American Journal of Sports Medicine ERGEBNISSE VON DEN BEIDEN Studien zeigen, dass Neocart SICHERE Verstärker ist wirksame Behandlung für Gelenkknorpel LÄSIONEN bis 5-Jahres-Nachuntersuchung (HSGX). 29 Patienten mit symptomatischen Volldicken-Knorpelschädigungen des distalen Femurkondylus wurden mit NeoCart in den klinischen Studien der Phase 1 und Phase 2 behandelt und für diese Analyse zusammengefasst. Sicherheit und Wirksamkeit wurden prospektiv durch MRT und Patienten berichtet Ergebnisse (PRO) über eine 60-Monats-Follow-up-Periode, mit 21 Patienten evaluiert zum letzten Zeitpunkt. Qualitative MRT-Metriken wurden nach modifizierter Magnetresonanzbeobachtung des Knorpelreparaturgewebes (: MOCART) - Kriterien mit einer zusätzlichen Bewertung der Intensität des Reparaturgewebes quantifiziert. Die NeoCart-Patienten wurden über 52 15,5 (median 60) Monate beobachtet. Die nachgewiesenen schnellen Reifung des Knorpels, wie die MRT-Daten aus den klinischen Studien der Phase 1 und Phase 2 zeigen, stimmt mit biomechanischen Daten überein, die kürzlich von Histogenics und Cornell University vorgestellt wurden Vitro-Knorpel-Konstrukte oder Gewebeimplantate, hergestellt unter Verwendung eines Verfahrens, das entworfen ist, um das von NeoCarT AUSSTELLTETE MECHANISCHE EIGENSCHAFTEN VOR DER IMPLANTATION, die ähnlich zu dem der NATIVE CARTILAGE. Diese Ergebnisse zeigen, dass die Reifung von Gewebezüchtungen CARTILAGE Implantate wie Neocart, verbesserten mechanischen Eigenschaften vor der Implantierung FÜHRT und in einer raschere Erholung und Rückkehr zu Funktion für Patienten mit Knorpelschäden ZUR FOLGE HABEN. 4:05 PM SONOCO-PRODUKTE SAGT DAS DURCHFÜHRUNG EINES 60 PRO TON-PREISES ERHÖHUNG FÜR ALLE GRADE VON UNCOATED RECYCLED PAPERBOARD IN DEN VEREINIGTEN STAATEN UND KANADA (SON). Sonoco kündigte bereits eine URB-Preiserhöhung von 40 bis 60 pro Tonne im Oktober 2016 an, und das Unternehmen revidiert die Erhöhung für alle Sorten bis 60 pro Tonne, wirksam mit Sendungen ab dem 6. Februar 2017. 4:05 pm Applied Optoelectronics erhöht Q4 EPS Und Einnahmen über Konsens (AAOI). "Wir haben ein starkes viertes Quartal mit Top - und Bottom-Line-Ergebnissen erwartet, die voraussichtlich unsere Führung übertreffen", sagte Dr. Thompson Lin, Applied Optoelectronics, Inc. Gründer, Präsident und CEO. "Die beschleunigte Nachfrage nach unseren marktführenden Rechenzentrenprodukten und die gesteigerte Kapazität haben unsere Ergebnisse angeheizt. Darüber hinaus trieben wir die Produktionseffizienz weiter, was zu einer Rekord-Bruttomarge beigetragen hat. Wir sind begeistert von der guten Ende des Jahres und freuen uns auf die zusätzlichen Details unserer vierten Quartal Performance auf unserer Telefonkonferenz im Februar. Quote Applied Optoelectronics Prelim Q4 0.77-0.82 (vor: 0,46-0,51) vs 0,50 Capital IQ Consensus SchätzungQ4 revs 84,5-84,8 MLN (VORHANG: 75-79 MLN) VS 77,51 MLN CAPITAL IQ CONSENSUS SCHÄTZUNG. GAAP - und Nicht-GAAP basierende Bruttomarge im Bereich von 37,6 auf 38,0, ÜBER DEM STAND DER AUSBLICK NON-GAAP von 34,0 mit einem Nettogewinn nach Steuern im Bereich von 13,0 Mio. auf 14,0 MILLIONEN UND NICHT-GAAP-Nettogewinn nach Steuern im 35.5.GAAP DIE REIHE VON 14,2 MILLIONEN AUF 15,2 MILLIONEN, DEN VORHERIGEN NICHT-GAAP-AUSBLICK VON 8,5 MILLIONEN AUF 9,5 MILLION. 04.03 GLOBAL PARTNER ACQUISITION SCHLIESST Unternehmens-Zusammenschluss MIT SEQUEL Jugend und Familie SERVICES (AKTIEN GESTOPPT) (GPAC): Sequel Jugend und Familie Services ist ein führender, nationaler Anbieter von diversifizierten Behavioral Gesundheit Dienstleistungen für Kinder, Jugendliche und Erwachsene mit Verhaltens-, Emotionale oder körperliche Herausforderungen. Mit dieser Transaktion wird Sequel eine Nasdaq-börsennotierte Aktiengesellschaft mit einem erwarteten anfänglichen Unternehmenswert von rund 423,3 Millionen werden. Unmittelbar nach Abschluss der Transaktion wird GPAC seinen Namen in Sequel Youth und Family Services, Inc. ändern. Im Rahmen des Unternehmenszusammenschlusses erhalten die Sequel-Stammaktieninhaber neu ausgegebene Sequel-Stammaktien, die zunächst für 4.500.000 Aktien der GPAC-Stammaktien, 105,0 Millionen, austauschbar sind In Bar und GPAC Optionsscheine auf den Kauf von 3.266.000 Aktien der GPAC Stammaktien. Die Sequel-Vorzugsaktionäre erhalten eine Barausschüttung in Höhe von 30,0 Mio. und rund 62,2 Mio. in neu ausgegebenen Sequel-Vorzugsaktien mit bestimmten Vorzugsrenditen und anderen Rechten. Vom 30. Juni 2011 bis zum 30. Juni 2011 bis zum 30. Juni 2016 , Der Sequels-Programmumsatz, der Gesamtumsatz und das bereinigte EBITDA stiegen bei den CAGRs von 12,1, 12,4 bzw. 13,8. Für das am 30. Juni 2016 endende Geschäftsjahr verzeichnete Sequel einen Umsatz von 208,0 Mio. Euro, einen Gesamtumsatz von 200,4 Mio. Euro, ein bereinigtes EBITDA von 31,3 Mio. und feste CASHFLOWs von 28,8 Mio. Euro. FÜR DAS GESCHÄFTSJAHR 30. Juni BEENDET 2017 SEQUEL PROGNOSEN PROGRAMM Erlöse, die Gesamtumsatzerlöse, bereinigtes EBITDA und Free Cash-Flows 253,9 MIO, 246,1 MIO, 39,7 Mio. und 36,8 Mio., was einer Steigerung von 22,1 REPRÄSENTIERT, 22,8, 26,8 und 27,8 bzw. AUS DEM GESCHÄFTSJAHR ZUM 30. JUNI 2016 15.43 OMNICOM TOCHTERGESELLSCHAFT DDB SAN FRANCISCO ERNANNT LEAD MARKETING PARTNER FÜR DIE ENERGIE CALIFORNIA PROGRAMM DER California Public Utilities Commission ARBEIT LAUNCH APRIL 2017 (OMK) ERWARTET AKTUALISIEREN. 3:29 PM PGampE beseitigt ungefähr 450 Unterstützungsdienste Arbeitsplätze auch ELIMINIERTE DIE ROLLE VON UNGEFÄHIG 800 NICHT-MITARBEITER-AUFTRAGNEHMERN AUS DEN UNTERNEHMEN (PCG). Diese prognostizierten Kostenreduzierungen spiegeln sich in der Guidance des Q3-Ergebnisses vom 4. November 2016 wider. Der größte Teil der Kostensenkungen wird aus der Verringerung der Material - und Kontraktausgaben, der Neuverhandlungen mit den Anbietern und der Reduzierung der Ausgaben für Fachkräfte resultieren Dienstleistungen und Ermessensausgaben. 15:18 Die Areva SA hat die EG-Genehmigung für die Durchführung der Kapitalerhöhungen von AREVA SA und NewCo (ARVCF) bestätigt. Generalversammlungen der Aktionäre AREVA SA und NewCo, die am 3. Februar 2017 bestätigt wurden, über die entsprechenden Kapitalerhöhungen nach der Genehmigung der Europäischen Kommission zu entscheiden. Der Ausgabepreis der neuen AREVA SA-Aktien in Höhe von 4,50 je Aktie im Einklang mit dem Preis eines öffentlichen Kaufangebots für die AREVA SA-Aktien (gefolgt von einem obligatorischen Squeeze-out), der vom französischen Staat, Nachdem die Neukapitalerhöhung durchgeführt wurde. Die Durchführung der Kapitalerhöhungen erfolgt, sobald die Voraussetzungen der Europäischen Kommission erfüllt sind. Einräumung von Fortschritten in den Eigentümer - KONTOKORRENT durch den französischen Staat die Gruppen LIQUIDITY BIS Durchführung der Kapitalerhöhung INCREASES. AREVA SICHERZUSTELLEN FINALIZING GESPRÄCHE MIT IHREN BANKING PARTNER SICHERN AUF EINEN die Vereinbarungen zur Einhaltung des NEWCO KAPITALERHÖHUNG VERFAHRENS UND AUF DER ANDEREN SEITE EINE BRÜCKE Darlehen in Höhe von 300 Millionen Euro auf weitere finanzielle Mittel von AREVA SA IM FALLE vorsehen, dass der Verkauf von neuen NP wurden am Ende verzögert werden 2017. 15.14 LOCKHEED MARTINS SIKORSKY erhielt den Auftrag FÜR PHASE 3 DER VERTEIDIGUNG FORTGESCHRITTENE PROJEKTE AGENTUREN (: DARPA) AIRCREW LABOR IN-COCKPIT AUTOMATION SYSTEM PROGRAM (LMT). 3:12 pm Fiat Chrysler namens Daphne Zheng als COO von China und Paul Alcala COO von AsiA PACIFIC REGIONEN (exklusive CHINA) (FCAU). Mike Manley, der die Asien-Pazifik-Region bis jetzt geführt hat, wird weiterhin auf der GEC und als Leiter von Jeep und Ram brandS GLOBALLY. 2:39 PM EATON VANCE AUTORISIERT REPURCHASE VON BIS ZU 8 MLN-AKTIEN AUCH ERKLÄRT UNGEKANNT 0.28SHARE QUARTAL DIVIDEND (EV). 1:22 pm Nexstar bestätigt, dass die FCC die Anträge und damit zusammenhängende Verzichtserklärungen von Media GENERAL (MEG) zusätzlich erteilt hat, hat die FCC auf das Verbot der Vollendung der Transactio verzichtet, die weiterläuft (NXST). 1:12 pm EnerJex Resources erhält ein Schreiben der Nichteinhaltung von der NYSE wegen des Versagens, eine jährliche Sitzung für das Geschäftsjahr zu halten, das am 31. Dezember 2015 (ENRJ) endet. 1:01 PM Willdan Group erhält neuen Dreijahres-, 75 Millionen Grundvertrag, um Con Edison (ED) des New Yorks kommerziellen Direktinstallationsprogramms über den Dienstprogrammen New York City und Westchester Grafschaft Service-Bereich (WLDN) zu implementieren. Dieses neue Programm ersetzt und erweitert Con Edisons Small Business Direct Install Programm, das Willdan seit 2009 implementiert hat, durch die Erhöhung der Größe der zugelassenen kommerziellen Kunden und die Diversifizierung der Programm-Angebote. Willdan erwartet, dass es Ergänzungen zu dem Basisvertrag gibt, der bis Ende des Jahres 2019 läuft. Der Basisvertrag umfasst nicht das Brooklyn Queens Neighborhood Program, Erweiterungen, die in dem vorgeschlagenen Fall für die gemeinsame Abwicklung beschrieben sind, oder zusätzliche Programmschwerpunkte. 1:00 pm Midday Market Zusammenfassung: Aktienkurse bescheiden niedriger am Mittag (: WRAPX): Aktien sind bescheiden niedriger am Nachmittag mit dem SampP 500 mit einem Verlust von 0,2. Der Dow Jones Industriedurchschnitt (0,1) übertrifft, gerade über seiner flachen Linie handelnd. Die heutige Sitzung begann mit einigen gemischten Corporate News. Signet Jewelers (SIG 84.15, -3.31) fiel um 3.8, nachdem das Unternehmen im vierten Quartal das Ergebnis je Aktie und gleichbleibende Verkaufsberatung auf der Rückseite von einigen schwachen Urlaub Verkäufe sank. Ford Motor (F 12,61, -0,24) ist auch ticken niedrigeren, 1,8 verlieren, trotz Ausgabe In-line-Führung an diesem Morgen. Umgekehrt ist United Continental (UAL 75.60, 1.94) höher als 2,7 nach dem Unternehmen erhöht seine vierte Quartal Einheit Umsatzberatung. Allerdings ist der größte Treiber des Marktes Präsident-Elect Trumps News-Konferenz, die vor nicht allzu langer Zeit endete. Most sectors remain near their flat lines as investors digest the news conference, which was short on detail regarding planned infrastructure spending. Financials, consumer discretionary, industrials, materials, technology, consumer staples, and real estate trade within 0.2 of their respective flat lines. Mr. Trump did express a desire to bring back pharmaceutical operations to the United States and voiced support for competitive drug price bidding. Biotechnology has plunged as a result, evidenced by the 3.3 decline in the iShares Nasdaq Biotechnology ETF (IBB 277.44, -9.06). The health care sector (-1.7) is also down, falling to the bottom of the leaderboard. On the flip side, the energy sector (1.1) LEADS ITS PEERS, RIDING ON A POSITIVE PERFORMANCE FROM CRUDE OIL. THE COMMODITY CONTINUES TO RISE, UP 3.3 AT 52.46BBL, DESPITE EIA DATA SHOWING NOTABLE INVENTORY BUILDS ON ALL FRONTS. THE UTILITIES SECTOR (0.5) IS THE ONLY OTHER SPACE CONVINCINGLY IN THE GREEN. U. S. TREASURIES SAW A SLIGHT UPTICK IN BUYING INTEREST IN THE WAKE OF MR. TRUMPS NEWS CONFERENCE. THE 10-YR YIELD IS DOWN TWO BASIS POINTS TO 2.36. ALSO OF NOTE, THE U. S. DOLLAR INDEX (101.93, -0.08) HAS RETURNED TO UNCHANGED AFTER SHOWING A SOLID GAIN IN MORNING ACTION. TODAYS ONLY ECONOMIC DATA WAS THE MBA MORTGAGE INDEX, WHICH CROSSED THE WIRES AT 7:00 AM ET THIS MORNING. THE INDEX CAME IN AT 5.8. 12:53 PM FINISH LINE INCREASES QUARTERLY DIVIDEND TO 0.11SHARE FROM 0.10SHARE ( FINL ). 12:30 pm Medovex enters into a distribution agreement with AlfaMed s. r.l. a supplier of innovative spine surgery equipment covers the distribution of its DenerveX System throughout Italy ( MDVX ). 12:20 pm Textron begins on-water testing for the fourth-generation Common Unmanned Surface Vehicle ( TXT ) : quotWe are excited to begin system level testing of our first UISS system with mine countermeasure capabilities for the U. S. Navy, quot says Vice President of Control and Surface Systems Wayne Prender. quotUnmanned technology has come such a long way, and we are looking forward to beginning to apply our critical technology to protect our Naval warfighters. quot THE TEXTRON SYSTEMS UNMANNED SYSTEMS FOURTH-GENERATION CUSV IS A MULTI-MISSION UNMANNED SURFACE VEHICLE WITH A LARGE, CONFIGURABLE PAYLOAD BAY. SINCE ITS FIRST DEMONSTRATION IN 2009, THE CUSV HAS SUCCESSFULLY COMPLETED SEVERAL PROMINENT EXERCISES WITH THE U. S. NAVY. 12:16 PM EARNINGS CALENDAR FOR WEDNESDAY, JANUARY 11TH (:SUMRX). TODAY AFTER THE CLOSE LOOK FOR THE FOLLOWING COMPANIES TO REPORT:KBHTOMORROW BEFORE THE OPEN LOOK FOR THE FOLLOWING COMPANIES TO REPORT:TSM, DAL, SJR, FCEL 12:03 PM KC SOUTHERN, WATCO, AND WTC INDUSTRIAL ANNOUNCE A JV INVESTMENT WHICH WILL FACILITATE AND EXPAND THE EXPORTATION OF LIQUID FUELS FROM THE US TO MEXICO ( KSU ). The joint venture partners will invest approximately U. S. 45 million in this phase of the project, which has an anticipated completion in the second quarter of 2017. It is projected that the terminal project will eventually include a storage facility that would provide retail fuels for the population of Central Mexico. 11:55 am European Markets Closing Prices (:SUMRX). European markets are now closed stock markets across Europe performed as follows: UKs FTSE: 0.2 Germanys DAX: 0.5 Frances CAC: 0.0 Spains IBEX: -0.6 Portugals PSI: -0.6 Italys MIB Index: 0.3 Irish Ovrl Index: 0.3 Greece ASE General Index: 0.4 11:42 am Floor Talk: Price Pushback (:TALKX) : The major indices were pushing their highs for the day as President-elect Trumps press conference got underway. Soon after the President-elect began his remarks, the major indices rolled over in uniform fashion, precipitated by a comment from President-elect Trump that there needs to be more competitive drug price bidding and that other industries also need to see more competition. THE HEALTH CARE SECTOR (-1.7) HAS BEEN A PACESETTER IN THE PULLBACK, AS BIOTECH AND MAJOR PHARMACEUTICAL STOCKS HAVE RETREATED ON THE HEADLINE, YET MOST SECTORS HAVE REACTED NEGATIVELY AS WELL. THE ISHARES NASDAQ BIOTECHNOLOGY INDEX (IBB 278.48, -8.02, -3.4) IS A NOTABLE UNDERPERFORMER. THE PRESS CONFERENCE IS STILL IN PROGRESS, ALTHOUGH THE KNEE-JERK SELL-OFF TO SOME TOUGH TALK ON THE NEED FOR INCREASED COMPETITION TO LOWER GOVERNMENT EXPENSES UNDERSCORES THE STOCK MARKETS SENSITIVITY TO POLITICAL HEADLINE RISK IN THE TRANSITION TO A NEW ADMINISTRATION. THE MAJOR INDICES ARE ALL AT SESSION LOWS NOW WHILE THE U. S. DOLLAR INDEX AND THE 10-YR NOTE ARE PUSHING SESSION HIGHS ON SOME RISK AVERSION ACTIVITY. 11:37 AM LOCKHEED MARTIN DROPS FOLLOWING COMMENTS FROM PRESIDENT-ELECT DONALD TRUMP REGARDING THE F-35 PROGRAM ( LMT ). 11:32 am Stocks drop to session low as President Elect Trump holds first press conference SampP 500 -0.2 QQQ -0.3, DIA 0.1 ( SPY ). 11:10 am PTC Therapeutics extends recent strength to 10-month high foLLOWING PRESENTATION AT JPM HEALTHCARE CONFERENCE ( PTCT ). 11:05 am Social Reality announces that SRAXmd reported record unaudited rev in 2016 bookings for Jan 2017 are up 100 vs Jan 2016 ( SRAX ). Dec 2016 unaudited rev for SRAXmd increased 90 yy from 2015 and fourth quarter unaudited rev for SRAXmd in 2016 surpassed the total annual rev recorded for SRAXmd in 2015 with an 85 unaudited yy growth for the fourth quarter. Based upon preliminary unaudited financial information, the SRAXmd product line finished the year with 2016 rev up 115 compared to rev accrued in 2015. 11:01 am Sinclair Broadcast comments on recent reports regarding its political coverage of the presidential campaigns calls the Washington Post a once respected newspaper ( SBGI ) : Excerpt form quotan Op Ed from the Company submitted to the Washington Post, THAT THE POST REFUSED TO PUBLISH. quot quotYour piece on Sinclairs political coverage was misleading and irresponsible. Many key facts were omitted, facts that your newspaper was aware of and refused to include in the article. Your story was largely based on details published in a Politico article from the PREVIOUS WEEK. SINCLAIR WENT ABOVE AND BEYOND WITH INTERVIEW OFFERS TO BOTH CAMPAIGNS. THIS WAS A FULLY-TRANSPARENT PROJECT CALLED quotBeyond the Podiumquot where candidates could speak directly and at length to viewers on key topics. The simple fact is that one candidate took advantage of this offer and the other did not. We did make a point to have a democratic party spokesperson or Clinton surrogate on each week. Yet those details were ignored in favor of a more salacious story smacking of intrigue and conspiracy. quot 11:01 am General Comm acquires Northpoint Consulting terms not disclosed ( GNCMA ). Northpoint provides consulting services like network analysis and security, cloud migration management and communications design, to many of the top Fortune 500 companies nationwide. 10:51 am Notable movers of interest MSM 7.7 on Q1 EPS beat, Q2 guidance ( SCANX ) : The following are some of todays most notable movers of interest, categorized by market capitalization (large cap over 10 billion and mid cap between 2-10 billion) and ranked by change (all stocks over 100K average daily volume). Large Cap Gainers WDAY (80.48 8.24): Higher after sell-side analyst highlights deal with large customer. MRK (62.99 5.12): Receives FDA acceptance of supplemental biologics license application for Keytruda in combo with chemotherapy for first-line treatment of metastatic non-squamous non-small cell lung cancer. UAL (76.51 3.87): Expects Q416 consolidated passenger unit rev to decline 1.25-1.75 (prior 3-4) compared to Q416. Large Cap Losers JNPR (27.84 -1.99): Downgraded to Sell from Hold at Deutsche Bank. EQT (62.58 -1.2): Downgraded TO MARKET PERFORM FROM OUTPERFORM AT BMO CAPITAL. Mid Cap Gainers MSM (99.31 7.74): REPORTS Q1 EPS BEAT, GUIDES Q2 EPS ABOVE CONSENSUS. GMED (26.73 5.57): REPORTS PRELIM Q4 SALES ABOVE CONSENSUS AND ISSUES FY17 GUIDANCE IN-LINE. Mid Cap Losers NICE (66.47 -4.03): Expects Q4 and FY16 revEPS to be at or above the mid-point of prior guidance, authorizes new amp expanded 150 mln share repurchase program, eliminates dividend starting 1Q17, amp commences 225 mln private offering of exchangeable senior notes due 2024. VIPS (11.07 -4.24): Initiated with a Underperform at Bernstein tgt 10. 10:45 am Cadence Design announces that AltaSens has adopted the Cadence Modus Test Solution for its mixed-signal next-generation image sensors ( CDNS ). 10:20 am Energy, transports, strong in early trade with metals, retail and bitoech lagging vs. SPY 0.1 ( SPY ). USO 1.25 UUP 0.89 IYT 0.62 OIH 0.58 HACK 0.47 DIA 0.28 XOP 0.17SLV -1.32 XME -0.92 XRT -0.89 GLD -0.77 XBI -0.59 IBB -0.42 XLRE -0.36 9:44 AM OPENING MARKET SUMMARY: STOCK MARKET OPENS FLAT (:WRAPX) : EQUITIES OPENED TODAYS SESSION FLAT WITH THE SampP 500 UNCHANGED FROM YESTERDAYS CLOSING LEVEL. THE DOW OUTPERFORMS SLIGHTLY WITH A 0.1 GAIN. THE UTILITIES SECTOR (0.3) HAS TAKEN THE EARLY LEAD, FOLLOWED BY MODEST GAINS FROM HEALTH CARE (0.2) AND CONSUMER STAPLES (0.1). CONVERSELY, AT THE BOTTOM OF THE LEADERBOARD IS TELECOM SERVICES (-0.9), FINANCIALS (-0.4), AND REAL ESTATE (-0.2). THE TOP-WEIGHTED TECHNOLOGY SECTOR (UNCH) HOVERS NEAR ITS FLAT LINE. TREASURIES ARE ALSO FLAT IN EARLY ACTION. THE 10-YR YIELD IS UNCHANGED AT 2.38. 9:40 AM BLUEROCK RESIDENTIAL GROWTH PRICES 4 MLN COMMON STOCK OFFERING AT 13.15SHARE --SHARES HALTED-- ( BRG ). 9:29 am On The Wires (:WIRES). XPO Logistics, Inc. (XPO) has been awarded a supply chain contract by global power leader Cummins Inc. (CMI) to support its customers worldwide. XPO Logistics will operate Cummins primary parts distribution center starting this month, managing approximately 800 workers and over 2,700 orders shipped daily. U. S. Geothermal (HTM) announced that the estimate of the geothermal reservoir capacity associated with its San Emidio II project has increased from the earlier estimate of 10 net megawatts, to an estimated generation capacity of up to 47 net megawatts. This increased capacity is in addition to the current 10 megawatts being produced by the existing San Emidio I plant. Hortonworks (HDP) announced an open source technology collaboration with Neustar (NSR) to create security and identity management tools for IoT devices. Major Korean service provider LG U (a member of the LG Group) has selected Juniper Networks (JNPR) technology for its next-generation 5G network upgrade, which includes the Juniper Networks virtual route reflector capability within the vMX, and the EX4300EX2200 Ethernet Switches. JetBlue (JBLU) announced its latest onboard enhancement: always-free Wi-Fi connectivity on every aircraft from the departure gate to the arrival gate. Perry Ellis International (PERY) entered into a license agreement with Euroneck, S. A. de CV to design and distribute mens neckties, bow ties, cummerbunds, pocket squares, ascots, winter and summer scarves and hosiery under the Perry Ellis and John Henry trademarks in Mexico. The collection will be distributed in department stores, specialty stores and ecommerce with a product launch in Spring 2017.Mentor Graphics Corp. (MENT) announced that TSMC (TSM) has extended its collaboration with Mentor Graphics on the Xpedition Enterprise platform in conjunction with the Calibre platform for the design and verification of TSMCs InFO (Integrated Fan-Out) packaging technology for multi-chip and chip-DRAM integration applications. Mentor developed new Xpedition functionality specifically to support InFO and enable the IC package designer to complete design tasks to TSMC specification. By leveraging the capabilities of both the Calibre and HyperLynx technologies, the new Xpedition functionality minimizes the designer effort and design rule checking cycles required to achieve a DRC-clean InFO GDS file. Verizon (VZ) completed what it believes is the first interoperability trial of NG-PON2 (next generation passive optical network) technology. ADTRAN (ADTN) participated in Verizons recent interoperability trial of NG-PON2 technology. The trial, which featured several different technology suppliers and was aligned with Verizons Open OMCI specification, proved that multi-vendor solutions for both the optical line termination on the service provider end and the optical network terminal on the customer end can greatly expand the bandwidth delivered without impacting existing broadband subscribers on the same fiber line. This trial further showcases the improved service scalability and operational elasticity that NG-PON2 provides. This includes the highest level of bandwidth flexibility, maximizing SDNNFV network automation and allowing for the rapid creation and delivery of customer services. Ericsson (ERIC) and Cisco (CSCO) are extending their strategic partnership to include a new Wi-Fi solution offering, named Evolved Wi-Fi Networks. EWN combines Ericssons 3GPP access, core networks and applications with Ciscos Wi - Fi portfolio, to provide reliable Wi-Fi with THE HIGHEST PERFORMANCE TO ERICSSONS MOBILE, CABLE AND OTHER INDUSTRIES CUSTOMERS. THE NEW YORK STOCK EXCHANGE, PART OF INTERCONTINENTAL EXCHANGE (ICE), ANNOUNCED PLANS TO EXPAND ITS FLOOR-BASED TRADING OPERATIONS, OFFERING INVESTORS EVEN GREATER ACCESS TO TRADE ALL U. S. SECURITIES FOR THE FIRST TIME WITH NYSES UNIQUE AND PROVEN MARKET MODEL. DISCOVER FINANCIAL SERVICES (DFS) AND PAYPAL (PYPL) HAVE SIGNED AN AGREEMENT MAKING PAYPAL MORE WIDELY AVAILABLE TO DISCOVER CARDMEMBERS, ACQUIRERS AND MERCHANTS. PAICE ENTERED INTO A SETTLEMENT AGREEMENT WITH VOLKSWAGEN (VLKAY), AUDI (AUDVF) AND PORSCHE (POAHY) REGARDING PAICES HYBRID VEHICLE PATENTS. TERMS OF THE AGREEMENT ARE CONFIDENTIAL. THE AGREEMENT BRINGS AN END TO ALL PENDING LEGAL ISSUES BETWEEN THE COMPANIES. PAICE AND THE ABELL FOUNDATION HAD FILED A PATENT INFRINGEMENT COMPLAINT WITH THE U. S. INTERNATIONAL TRADE COMMISSION ( ITC ) in April 2016. A hearing at the ITC was scheduled for January 2017. 9:18 am Terreno Realty reports its operating, investment and capital markets activity for the 4Q16 ( TRNO ) : As of December 31, 2016, Terreno Realty Corporation owned 166 buildings aggregating 12.0 million square feet and five improved land parcels consisting of 22.8 acres. Key operating measures were as follows: The total portfolio was 97.4 leased to 376 tenants as compared to 96.4 at September 30, 2016 and 91.5 at December 31, 2015 The same store portfolio of 8.6 million square feet was 99.0 leased at December 31, 2016 as compared to 97.9 at September 30, 2016 and 92.6 at December 31, 2015 Cash rents on new and renewed leases totaling 0.6 million square feet commencing during the fourth quarter increased 1.8 million square feet commencing during the twelve months ending December 31, 2016 increased approximately 19.2. 9:16 am Numerex Corp. terminates the employment of Marc Zionts as CEO CFO Kenneth Gayron will assume the additional role of interim CEO names Kelly Gay as COO anticipates revenue will improve on a yy basis next year ( NMRX ). Mr. Zionts termination was not related to any Company accounting, internal controls, or financial reporting matter. Kenneth Gayron, the Chief Financial Officer, will assume the additional role of interim CEO working in close conjunction with the full Board while the Company conducts a search for a permanent CEO. In addition, Kelly Gay has agreed to join Numerex as its Chief Operating Officer and will work closely with Ken to manage the Companys array of security and IoT solutions and diversified customer base. Ms. Gays previous experience includes operating Numerexs security and judicial product lines as President of Security Solutions, and she contributed to several of the Companys strategic initiatives. The Company is expected to significantly improve its EBITDA performance over 2016 with estimates of adjusted EBITDA ranging from 8.5 million to 10 million. Revenue is anticipated to improve on a year-over-year basis, as well. The Company will provide an estimate of full year revenue expectations by its next scheduled results conference call. 9:14 am SampP futures vs fair value: 1.50. Nasdaq futures vs fair value: 4.80. (:WRAPX) : The stock market is poised for a slightly higher open as the SampP 500 futures trade two points above fair value. Crude oil is up for the first time in three days amid reports that Saudi Arabia, the worlds top exporter, plans to cut supply to Asia. The commodity is higher by 0.4, trading at 51.03bbl. On the corporate front, United Continental (UAL 75.00, 1.34) is higher by 1.8 in pre-market trade after the company raised its fourth quarter unit revenue guidance. Conversely, Ford Motor (F 12.75, -0.10) is ticking lower by 0.8 despite reaffirming its adjusted pre-taX PROFIT OUTLOOK FOR 2016 AND ITS BELIEF THAT ADJUSTED PRE-TAX PROFIT IN 2017 WILL BE SOMEWHAT LOWER THAN 2016. SIGNET JEWELERS (SIG 83.90, -3.56) IS ALSO DOWN, LOSING 4.1, AFTER THE COMPANY CUT ITS FOURTH QUARTER EARNINGS PER SHARE AND SAME-STORE SALES GUIDANCE RANGES ON THE BACK OF SOME WEAK HOLIDAY SALES. U. S. TREASURIES HAVE SEEN A SLIGHT UPTICK IN BUYING INTEREST WITH THE 10-YR YIELD DOWN ONE BASIS POINT TO 2.37. ALSO OF NOTE, THE U. S. DOLLAR INDEX (102.39, 0.38) IS HIGHER BY 0.4 AMID WEAKNESS IN BOTH THE EURO (1.0513) AND THE JAPANESE YEN (116.19). WHILE THERE ARE NO MAJOR ECONOMIC REPORTS TODAY, PRESIDENT-ELECT TRUMPS quotgeneral news conferencequot is likely to be scrutinized by investors. Mr. Trump is scheduled to speak from the Trump Tower lobby at 11 am ET. 9:09 am US Geothermal announces that the estimate of the geothermal reservoir capacity associated with its San Emidio II project has increased from the earlier estimate of 10 net megawatts, to an estimated generation capacity of up to 47 net megawatts ( HTM ). Co states, quotquotHaving the ability to add a larger power plant to our San Emidio complex will help reduce capital and operating costs, and give us a very cost competitive project. Additionally, it will allow us to deploy two, or possibly three, of the previously acquired power plants whose acquisition we had announced in early 2016.quot 9:07 am Intuitive Surgical issues upside prelim Q4 sales ( ISRG ). Co sees Q4 revs 757 mln vs 739.68 mln Capital IQ Consensus EstimateIn 2016, appROXIMATELY 753,000 SURGICAL PROCEDURES WERE PERFORMED WITH THE DA VINCI SURGICAL SYSTEM, AN INCREASE OF APPROXIMATELY 15 COMPARED WITH APPROXIMATELY 652,000 PROCEDURES PERFORMED IN 2015. THE GROWTH IN OVERALL 2016 PROCEDURE VOLUME WAS PRIMARILY DRIVEN BY THE GROWTH IN U. S. GENERAL SURGERY PROCEDURES AND WORLDWIDE UROLOGIC PROCEDURES. DA VINCI PROCEDURES INCREASED APPROXIMATELY 15 FOR THE FOURTH QUARTER OF 2016 COMPARED WITH THE FOURTH QUARTER OF 2015. THE COMPANY EXPECTS TOTAL DA VINCI PROCEDURES TO GROW APPROXIMATELY 9 TO 12 IN 2017.quotWe are pleased by our fourth quarter results and encouraged by our future opportunities. In 2017, we look forward to advancing several key product development innovations targeted towards further improving patient outcomes and expanding the number of patients that can derive the benefits of robotically assisted minimally invasive therapies around the world. We anticipate accelerating up to 80 million of research, development, and clinical investment into 2017.quot 9:07 am Endurance International announces that Google ( GOOGL ) Domains has selected its Bluehost brand to provide WordPress hosting solutions to new and existing customers ( EIGI ). 9:05 am McClatchy to sell amp lease back real property owned by The Sacramento Bee in Sacramento, California and The State Media COMPANY IN SOUTH CAROLINA FOR 67.8 MLN ( MNI ). These transactions are subject to customary closing conditions and are expected to close in the second quarter of 2017.Upon closing of the transactions, the company is required to first offer the after-tax proceeds from the sales at par to the secured bondholders in accordance with the indenture for its secured 9.0 bonds maturing in 2022. Under the indenture for its unsecured bonds, the company has 90 calendar days to reduce deBT EQUAL TO APPROXIMATELY 48.0 MILLION (SUBJECT TO CHANGE BASED ON MARKET RATES AT THE CLOSING OF THE TRANSACTIONS), WHICH REFLECTS THE ATTRIBUTABLE DEBT ASSOCIATED WITH THE LEASES. SHOULD THE SECURED BONDHOLDERS CHOOSE NOT TO PARTICIPATE IN THE PAR OFFER, THE COMPANY MAY ALTERNATIVELY SEEK TO REDUCE SOME OF ITS UNSECURED BONDS WITH THE AFTER-TAX PROCEEDS IN ORDER TO MEET ITS 90-CALENDAR-DAY REQUIREMENT FOR DEBT REDUCTION. 9:03 AM KLX ANNOUNCES NEW BUSINESS AWARDS FOR ITS AEROSPACE SOLUTIONS GROUP BUSINESS VALUED AT APPROX. 300 MLN IN THE AGGREGATE ( KLXI ). Co states, quotAs indicated on our most rECENT EARNINGS CALL, THESE NEW PROGRAM AWARDS WERE IN THE PROCESS OF NEGOTIATION DURING THE FOURTH QUARTER AND HAVE NOW BEEN OFFICIALLY AWARDED TO KLX. THESE NEW PROGRAMS ARE EXPECTED TO GENERATE APPROXIMATELY 60 MILLION PER YEAR IN ADDITIONAL ANNUAL REVENUES AFTER A 12 MONTH TRANSITION PERIOD. quot 9:03 am Landauer announces agreement with Gilead Capital, agrees to appoint its Chief Investment Officer, Managing Partner, and Co-Founder Jeffrey A. Strong to the Board ( LDR ). Strongs appointment is part of an agreement with Gilead Capital LP, under which Gilead has agreed to withdraw its slate of director nominees for election at the 2017 Annual Meeting, to vote for all of Landauers director nominees, and TO OTHER CUSTOMARY STANDSTILL PROVISIONS. PURSUANT TO THE AGREEMENT WITH GILEAD, THE COMPANY HAS ALSO AGREED TO APPOINT A NEW INDEPENDENT DIRECTOR MUTUALLY AGREEABLE WITH GILEAD FOR ELECTION AT THE 2018 ANNUAL MEETING OF STOCKHOLDERS 9:03 AM IMMUNOMEDICS SHAREHOLDER VENBIO SENDS LETTER TO THE BOARD OF IMMU NOMINATES 4 CANDIDATES FOR ELECTION TO THE COS BOARD AT THE UPCOMING 2016 ANNUAL MEETING ( IMMU ) : Highlights of the letter (as stated by venBio Select Advisor): Believes change is urgently needed to build sustained stockholder value and cORRECT STRING OF STRATEGIC MISSTEPS. CITES COMPANYS FAILURE TO MEANINGFULLY ADVANCE IMMU-132 DRUG CANDIDATE FOR TRIPLE NEGATIVE BREAST CANCER. STOCKHOLDERS SHOULD NOT BE DISTRACTED BY REACTIVE RECENT ANNOUNCEMENTS FROM COMPANY, INCLUDING NEW BOARD NOMINEES. VENBIOS BOARD NOMINEES -- IN CONTRAST TO COMPANYS CANDIDATES -- POSSESS THE RIGHT EXPERIENCE AND ABILITY TO DELIVER IMPORTANT TREATMENT OPTIONS FOR PATIENTS. URGES STOCKHOLDERS TO VOTE FOR VENBIOS FOUR NOMINEES ON THE GOLD PROXY CARD. 9:01 AM BELDEN AND CORNING ( GLW ) announce a technical collaboration in the broadband connectivity field resolves pending patent infringement and related proceedings between the cos involving Cornings EFC series of coaxial cable connectors, terms not disclosed ( BDC ). quotWe expect the macrO TRENDS ENABLING THE GROWTH OF THIS TECHNOLOGY TO CONTINUE IN THE FUTURE, AS BANDWIDTH INTENSITY, CLOUD COMPUTING, AND THE NUMBER OF DEVICES CONNECTED TO THE INTERNET CONTINUE TO GROW EXPONENTIALLY. quot 9:01 am Vertex Pharma licenses 4 oncology researchdevelopment programs to Merck KGaA ( MKGAY ) for an upfront payment of 230 mln plus royalties on futures sales ( VRTX ) : quotWith this strategic deal, we significantly strengthen our oncology pipeline in two attractive areas where we have leading competence, DNA damage and repair and immuno-oncology - areas which also have promising therapeutic synergy, quot said Belen Garijo, CEO Healthcare and Member of the Executive Board of Merck KGaA, Darmstadt, Germany. quotThis deal underscores our commitment to accelerate innovation for cancer patients, and we are excited for the opportunity to build on Vertexs rigorous science and advance these leading programs. quot The two clinical-stage programs represent first-in-class approaches to inhibit the DNA repair pathways that are fundamental to the survival and proliferation of certain cancers: An ataxia telangiectasia and Rad3 related ( ATR ) protein kinase inhibitor program comprised of two compounds, VX-970 and VX-803. VX-970 is being investigated broadly through 10 ongoing Phase 1 and Phase 2 trials across a variety of tumors and patient subtypes expected to be responsive to ATR inhibition based on biomarker data. Preliminary VX-970 clinical data were presented at the 2016 American Society of Clinical Oncology (:ASCO) Annual Meeting and the 2016 American Association for Cancer Research (:AACR) Annual Meeting. VX-803 is an orally dosed ATR inhibitor currently in Phase 1 trials evaluating escalating doses of VX-803 alone and in combination with chemotherapy. A DNA-dependent protein kinase (DNA-PK) inhibitor program including the clinical candidate VX-984. A Phase 1 trial is now evaluating escalating doses of VX-984 alone and in combination with pegylated liposomal doxorubicin in subjects with advanced solid tumors. Merck KGaA, Darmstadt, Germany will combine these assets with its existing DNA-PK assets into a single development program. The collaboration, and the related 230 million upfront payment, is subject to the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act. 8:57 am On The Wires (:WIRES). Hemispherx Biopharma (HEB) announced that the rintatolimod European early access program designed to enable access of the compound to MECFS patients has been extended to pancreatic cancer patients beginning in the Netherlands. The first patient was dosed and several other patients are in the queue to receive rintatolimod. MyTomorrows, Hemispherx exclusive service provider in Europe and Turkey, will manage all EAP activities relating to the extension in addition to its existing activities regarding early access use in chronic fatigue syndrome patients. Corephotonics, a startup developing dual camera technologies for smartphones, recently completed a 15 million funding round. To date, the company has raised more than 50 million. Participating in the current funding round are a number of strategic investors: Samsung (SSNLF) Ventures, Foxconn (FXCNY), Taiwans MediaTek, and a tier-1 smartphone OEM. Two additional investment funds participated in this funding round, one from China and the other from Hong Kong. Enel S. p.A. (ENLAY), through its subsidiary Enel Green Power North America, Inc. has acquired a 100 percent stake in Demand Energy Networks, Inc. a US-based company specialised in intelligent software and energy storage systems. Demand Energys core experience is in the behind-the-meter storage market. The company has carried out 24 projects since its creation, totalling 3 MW9 MWh of installed capacity in both the USA and Latin America, and boasts a pipeline in excess of 30 MW100 MWh. 8:52 am SampP futures vs fair value: -1.30. Nasdaq futures vs fair value: 1.00. (:WRAPX) : The SampP 500 futures trade one point below fair value. Markets in the Asia-Pacific region ended Wednesday on a mixed note, but the trading day was fairly quiet. The World Bank did lower its GDP growth outlook for 2017 and 2018, but the adjustment only reduced the previous forecast by 10 basis points. The forecast for 2017 was lowered to 2.7 from 2.8. The U. S. growth forecast for 2017 was maintained at 2.2 due to the expected impact of fiscal stimulus under the new administration. In economic data: Japans November Leading Index 102.7 (expected 102.6 previous 100.8). November Coincident Indicator 1.6 month-over-month (last 1.0) South Koreas December Unemployment Rate declined to 3.4 from 3.6. December Import Price Index 9.2 year-over-year (last 3.6) and December Export Price Index 6.3 year-over-year (last 3.5) ---Equity Markets--- Japans Nikkei added 0.3. Growth-sensitive names like SUMCO, Nippon Sheet Glass, Kobe Steel, Sumitomo Metal Mining, Japan Steel Works, Mitsubishi Materials, and Ebara posted gains between 2.0 and 4.4. Hong Kongs Hang Seng climbed 0.8 amid strength in property names and financials. Sino Land, New World Development, Hang Lung Properties, Cheung Kong Property Holdings, China Overseas, Bank of China, Ping An Insurance, and HSBC added between 0.8 and 3.8. China Unicom Hong Kong lagged for the second day in a row, falling 2.0. Chinas Shanghai Composite lost 0.8. Shang Gong Group, Tianjin Global Magnetic Card, Wuhan Hanshang, and Shen Ma Industry registered losses between 5.4 and 6.8. Indias Sensex added 0.9 with help from most components. Coal India spiked 5.4 while other growth-sensitive names like Tata Steel, Larsen amp Toubro, Power Grid, and MahindraampMahindra rallied between 1.3 and 4.0. Bajaj Auto was the weakest performer, falling 0.9. Major European indices trade slightly above their flat lines with Germanys DAX (0.3) showing relative strength. Although equity markets have maintained narrow ranges so far, the euro has retreated steadily, falling 0.5 against the dollar to 1.0508. The decline leaves the single currency in the bottom half of its trading range that dates back to early December. The British pound has also retreated against the dollar, surrendering 0.5 to 1.2121, despite above-consensus economic data. On balance, economic data received since the Brexit vote has been strong relative to expectations. In economic data: UKs November Industrial Production 2.1 month-over-month (expected 0.8 last -1.1) 2.0 year-over-year (consensus 0.6 previous -0.9). November Manufacturing Production 1.3 month-over-month (expected 0.5 last -1.0) 1.2 year-over-year (consensus 0.4 last -0.5). November Construction Output -0.2 month-over-month (expected 0.3 last -0.6) 1.5 year-over-year (consensus 2.0 previous 0.7). November trade deficit widened to GBP12.16 billion from GBP9.89 billion (expected deficit of GBP11.20 BILLION) SPAINS NOVEMBER INDUSTRIAL PRODUCTION 3.2 YEAR-OVER-YEAR (CONSENSUS 1.0 LAST 0.6) ---EQUITY MARKETS--- GERMANYS DAX IS HIGHER BY 0.3 WITH HEAVYWEIGHTS VOLKSWAGEN, DEUTSCHE BANK, DAIMLER, AND MERCK AMONG THE LEADERS. THE FOUR NAMES ARE UP BETWEEN 1.0 AND 2.8. ON THE DOWNSIDE, SIEMENS AND BMW ARE DOWN 1.2 AND 0.1, RESPECTIVELY. FRANCES CAC HAS ADDED 0.1 AMID RELATIVE STRENGTH IN AUTOMAKERS. PEUGEOT AND RENAULT HOLD RESPECTIVE GAINS OF 3.4 AND 0.5 WHILE MICHELIN HAS ADDED 1.3. FINANCIALS TRADE IN THE RED WITH BNP PARIBAS, SOCIETE GENERALE, AND CREDIT AGRICOLE DOWN BETWEEN 0.4 AND 0.6. UKS FTSE IS HIGHER BY 0.2 THANKS TO GAINS IN CONSUMER NAMES. DIXONS CARPHONE, SAINSBURY, MARKS amp SPENCER, AND UNILEVER SHOW GAINS BETWEEN 0.6 AND 3.4. SELECT FINANCIALS LAG WITH RBS, fx, STANDARD LIFE, AND RSA INSURANCE DOWN BETWEEN 0.2 AND 2.0. ITALYS MIB HAS ADDED 0.1. FINANCIALS LIKE BANCO BPM, BANCA POP EMILIA ROMAGNA, UNICREDIT, MEDIOBANCA, AND INTESA SANPAOLO ARE DOWN BETWEEN 0.1 AND 2.7. 8:45 AM MAGNACHIP SEMI UPSIZES amp PRICES A 75 MLN 5.00 EXCHANGEABLE SENIOR NOTES OFFERING ( MX ). The notes will be exchangeable at the option of the holder into shares of the cos common stock at an initial exchange rate of 121.1387 shares of common stock per 1,000 principal amount of notes, which is equivalent to an exchange price of 8.26share. The notes will bear interest at a rate of 5.00year, payable semi-annually in cash, in arrears, on each Mar 1 and Sept 1, beginning on Mar 1, 2017.The co plans to use the net proceeds from the offering of the notes (i) for its anticipated cost reduction program to be implemented during the first half of 2017 ( 30-40 mln), (ii) for capex ( 15-20 mln), (iii) to repurchase common stock as part of its stock repurchase program (up to 15 mln) and (iv) for general corporate purposes. 8:36 am Gapping down ( SCANX ) : Gapping down In reaction to disappointing earNINGSGUIDANCE: NVDQ -17.3, (SEES Q4 REV BELOW CONSENSUS SEES FY17 REV BELOW CONSENSUS), SVU -8.1, SIG -4.6, BWA -1.9, LMNR -1.6 MampA news: ADM -5.6 (to acquire Crosswind Industries terms not disclosed) Select pharma related names showing weakness: BMY -3.6, AZN -1.6, SHPG -1.1 Other news: SGNL -12.8 (pulling back following recent strength)ETRM -11.2 (pulling back following recent strength)GNVC -7.4 (pulling back following recent strength)PTN -5.3 (Palatin Technologies to hold call following closing of licensing agreement with AMAG Pharmaceuticals for North American rights to Rekynda)PFGC -5 (prices 10 mln common stock offering by certain of its stockholders, INCLUDING AFFILIATES OF THE BLACKSTONE GROUP ( BX ) at 22.85share )BRG -4.7 (commenced a public offering of 4,000,000 shares of its Class A common stock)TERP -4.5 (Brookfield Asset Management affirms 12.12 active stake, discloses the submission of alternative proposals to the companys advisors with respect to a potential transaction involving the company andor TerraForm Global)PE -2.9 (announces Midland Basin and DELAWARE BASIN ACQUISITIONS AND INTRODUCES 2017 CAPITAL PROGRAM AND OPERATING GUIDANCE EXPECTS 60 ANNUAL PRODUCTION GROWTH IN 2017 COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF 20,000,000 SHARES OF CLASS A COMMON STOCK). Analyst comments: HIMX -2.5 (downgraded to Neutral from Buy at ROTH Capital)WUBA -1.6 (INITIATED WITH A UNDERPERFORM AT BERNSTEIN)JD -1 (INITIATED WITH AN UNDERPERFORM AT BERNSTEIN )C -0.8 (DOWNGRADED TO SELL AT UBS)BIDU -0.7 (INITIATED WITH A UNDERPERFORM AT BERNSTEIN) 8:34 AM BROADCOM ANNOUNCES PRIVATE OFFERING OF SENIOR NOTES ( AVGO ). The notes will be guaranteed on a senior unsecured basis by Broadcom and certain of its other subsidiaries. The Co-Issuers intend to use the net proceeds from the sale of the notes to repay indebtedness outstanding under Broadcoms credit facility and to pay related fees and expenses. 8:33 am Gulf Resources announces the completion of its first brine water and natural gas well field construction in Sichuan Province expect to be able to begin trial production iN THE VERY NEAR FUTURE ( GURE ). 8:32 am Rockwell Automation appoints VP investor relations and VP, finance, of the Architecture amp Software Patrick Goris as CFO effective Feb. 7 ( ROK ). 8:31 am Great Panther Silver announces Q4 production highlights co expects 2017 production level of 4.0-4.1 million Ag eq oz (at a 70:1 ratio) from its Mexico operations ( GPL ) : 2016 Production Highlights (Compared to Full Year 2015) Consolidated metal production -7 to 3,884,960 silver equivalent ounces Silver production -14 to 2,047,260 silver ounces Gold production 2 to 22,238 gold ounces Ore processed was steady at 376,739 tonnes 4Q16 Production Highlights (Compared to Fourth Quarter 2015) Consolidated metal production decreased 12 to 883,772 Ag eq oz Silver production decreased 17 to 460,571 Ag oz Gold production decreased 8 to 5,206 Au oz Ore processed decreased 2, with 92,869 tonnes milled 8:30 am Ecolab acquires Abednego Environmental Services terms not disclosed ( ECL ). Abednego is a privately held company with 40 million in annual revenues that provides chemistry and service solutions to help automotive customers in their paint operations. 8:30 am SampP futures vs fair value: -2.00. Nasdaq futures vs fair value: -0.40. (:WRAPX) : The stock market is on track for a slightly lower open as the SampP 500 futures trade two points below fair value. The slow start to the day follows a notably quiet night of corporate news. Rite Aid (RAD 8.65, 0.33) is higher by 4.0 this morning on the heels of a New York Post report that the FTC could be near approving the companys pending sale to Walgreens Boot Alliance (WBA 82.67, 0.00). Conversely, Signet Jewelers (SIG 83.25, -4.21) is ticking lower by 4.8 after lowering its Q4 earnings and comparable sales guidance amid disappointing holiday results. U. S. TREASURIES HAVE SEEN A SLIGHT UPTICK IN BUYING INTEREST WITH THE 10-YR YIELD DOWN ONE BASIS POINT TO 2.37. ALSO OF NOTE, THE U. S. DOLLAR INDEX (102.44 0.43) IS HIGHER BY 0.4 AMID WEAKNESS IN BOTH THE EURO (1.0505) AND THE JAPANESE YEN (116.23). WHILE THERE ARE NO MAJOR ECONOMIC REPORTS TODAY, PRESIDENT-ELECT TRUMPS quotgeneral news conferencequot is likely to be analyzed by investors. Mr. Trump is scheduled to speak from the Trump Tower lobby at 11 am ET. 8:30 am Gapping up ( SCANX ) : Gapping up In reaction to strong earningsguidance: ICHR 9, (sees Q4 revs 131 mln vs 117.90 mln Capital IQ Consensus Estimate, expects Q1 sales to be higher than Q4)MSM 2.5, DE 1.2, (light volume releases December retail sales update)MX 0.8, (MagnaChip Semi reports prelim Q4 sales at high end of guidance above consensus announces proposed 65 mln private offering of exchangeable senior notes and stock repurchase)VRX 0.5, (reiterates FY16 guidance) MampA news: DSCI 41 (to be acquired by Integra LifeSciences ( IART ) for 7.00 per share)RAD 4 (NY Post discusses that regulators might complete review of Walgreens ( WBA ) and Rite Aide ( RAD ) merger before President Obama leaves office), Other news: BIOC 43.1 (continued strength)ENPH 22.1 (announces a 10 mln private placement of its common stock to T. J. Rodgers and John Doerr, chairman of Kleiner Perkins Caulfield amp Byers)TGTX 10 (completion of enrollment in part 1 of its phase II study of TG-1101)AKAO 9.3 (Baker Bros discloses 13.1 passive stake)SGMO 6.8 (granted orphan designation by the FDA for its compound for the treatment of mucopolysaccharidosis type I )CTSO 6.3 (light volume CytoSorbents and the U. S. Air Force determine to close the Company-sponsored, 30 patient, single site, randomized controlled human pilot study of the CytoSorb product to evaluate patients with severe trauma and rhabdomyolysis)ARLZ 4.2 (USPTO has issued patent covering Yosprala which will expire in late 2032 with possible patent term adjustment into early 2033)MRK 3.1 (receives FDA acceptance of supplemental biologics license application for Keytruda in combo with chemotherapy for first-line treatment of metastatic non-squamous non-small cell lung cancer)RDHL 2.9 (RHB-104 has been granted QIDP designation by the FDA for the treatment of Nontuberculous Mycobacteria infection)UAL 2.8 (expects Q416 consolidated passenger unit rev to decline 1.25-1.75 (prior 3-4) compared to Q416)GST 2.1 (declares special cash dividends on 8.625 Series A Preferred Stock and 10.75 Series B Preferred Stock enters into related amendment of credit agreement)AAL 1.6 (reports December traffic, raises Q4 TRASM, pre-tax margin RPMs -0.8 yy)MYL 1 (FDA has accepted Mylans biologics license application for MYL-1401O, a proposed biosimilar trastuzumab) Analyst comments: KERX 4.8 (upgraded to Neutral from Sell at Citigroup)BT 2.7 (upgraded to Overweight from Equal Weight at Morgan Stanley)ESV 1.7 (upgraded to Buy from Neutral at Citigroup)WRD 1.7 (initiated with a Strong Buy at Raymond James)PANW 0.8 (initiated with Outperform ratings at Wells Fargo) 8:29 am On The Wires (:WIRES). IBM Watson Health (IBM) has signed a research initiative with the FDA aimed at defining a secure, efficient and scalable exchange of health data using blockchain technology. IBM and the FDA will explore the exchange of owner mediated data from several sources, such as Electronic Medical Records, clinical trials, genomic data, and health data from mobile devices, wearables and the quotInternet of Things. quot The initial focus will be on oncology-related data. Bird Rock Bio announced that it has received approval for the initiation of a two-part Phase 1 clinical trial for namacizumab, a novel therapeutic antibody to the cannabinoid 1 receptor. In addition, Bird Rock Bio has entered into an agreement with GE Healthcare (GE) for process development, formulation, and manufacture of namacizumab in preparation for Phase 2 studies. Furthermore, the Phase 1 trial, process development, and Phase 2 preparation will be funded under a collaboration and option agreement with Janssen Pharmaceuticals (JNJ). THE J. M. SMUCKER COMPANY (SJM) ANNOUNCED AN INCREASE IN THE LIST PRICE FOR THE MAJORITY OF ITS PACKAGED COFFEE PRODUCTS SOLD IN THE UNITED STATES, PRIMARILY CONSISTING OF ITEMS SOLD UNDER THE FOLGERS, DUNKIN DONUTS, AND CAF BUSTELO BRAND NAMES. PRICES INCREASED AN AVERAGE OF SIX PERCENT ON IMPACTED ITEMS IN RESPONSE TO SUSTAINED INCREASES IN GREEN COFFEE COSTS. THE COMPANYS K-CUP PODS WERE EXCLUDED FROM THE PRICE INCREASE. SUBSIDIARIES OF IMPERIAL BRANDS PLC (IMBBY) AND CHINA TOBACCO HAVE ESTABLISHED A DYNAMIC LONG-TERM JOINT VENTURE BUSINESS WHICH WILL LOOK TO DEVELOP A VARIETY OF GROWTH OPPORTUNITIES IN CHINA AND INTERNATIONAL MARKETS. GLOBAL HORIZON VENTURES LIMITED IS INITIALLY FOCUSED ON: LEVERAGING THE EXPERTISE OF CHINAS LARGEST TOBACCO COMPANY, YUNNAN TOBACCO, TO DRIVE THE SUSTAINABLE GROWTH OF IMPERIALS GROWTH BRANDS WEST AND DAVIDOFF IN CHINA AND MAXIMISING THE POTENTIAL OF TWO YUNNAN BRANDS, JAD AND HORIZON, IN MARKETS OUTSIDE OF CHINA. AT ITS BOARD MEETING, SNCF SELECTED THE ALSTOM (ALSMY)-BOMBARDIER (BDBRF) CONSORTIUM TO RENEW THE TRAINS ON LINES D AND E OF THE LE-DE-FRANCE NETWORK. THIS CONTRACT FOR 255 TRAINS (130 FOR THE RER D AND 125 FOR THE RER E), WORTH AN ESTIMATED 3.75 BILLION EUROS, IS THE LARGEST CONTRACT EVER FINANCED BY STIF. 8:05 AM TAKEDA PHARMA INVESTS 125 MLN IN MAVERICK THERAPEUTICS, INCLUDING OPTION-TO-ACQUIRE ( TKPYY ) : Cos entered a collaboration to develop Mavericks T-cell engagement platform created specifically to improve the utility of T-cell redirection therapy for the treatment of cancer. The 125 million of funding includes an upfront option, equity and RampD funding payments, and provides Takeda the exclusive right to purchase Maverick after five years for an undisclosed sum. 8:03 am SampP futures vs fair value: -1.80. Nasdaq futures vs fair value: 0.10. (:WRAPX) : Equity futures point to a slightly lower open on Wednesday morning as the SampP 500 futures trade two points below fair value. Global markets are mixed with Asia closing on a mostly higher note while European indices hover near their flat lines. Crude oil is up for the first time in three days amid reports that Saudi Arabia, the worlds top exporter, plans to cut supply to Asia. The commodity is higher by 0.4, trading at 51.03bbl. U. S. Treasuries are flat this morning amid an uptick in the U. S. dollar. The 10-yr yield remains unchanged at 2.38, while the U. S. Dollar Index (102.39, 0.38) is up 0.4. Todays only economic data was the MBA Mortgage Index, which crossed the wires at 7:00 am ET this morning. The index came in at 5.8. In U. S. corporate news of note: Tesla Motors (TSLA 229.00, -0.87): -0.4 after the company named Apple (AAPL 118.75, -0.36) engineer Chris Lattner vice president of autopilot software. Ford Motor (F 12.72, -0.13): -1.0 despite reaffirming positive guidance for 2017.Citigroup (C 59.80, -0.43): -0.7 after the stock was downgraded to Sell at UBS. Reviewing overnight developments: Markets in the Asia-Pacific region ended Wednesday on a mixed note, but the trading day was fairly quiet. Japans Nikkei 0.3, Hong Kongs Hang Seng 0.8, Chinas Shanghai Composite -0.8, Indias Sensex 0.9.In economic data: Japans November Leading Index 102.7 (expected 102.6 previous 100.8). November Coincident Indicator 1.6 month-over-month (last 1.0) South Koreas December Unemployment Rate declined to 3.4 from 3.6. December Import Price Index 9.2 year-over-year (last 3.6) and December Export Price Index 6.3 year-over-year (last 3.5)In news:The World Bank lowered its GDP growth outlook for 2017 and 2018, but the adjustment only reduced the previous forecast by 10 basis points. The forecast for 2017 was lowered to 2.7 from 2.8. The U. S. growth forecast for 2017 was maintained at 2.2 due to the expected impact of fiscal stimulus under the new administration. Major European indices trade near their flat lines with Germanys DAX showing relative strength while Italys MIB underperforms. Germanys DAX 0.2, FRANCES CAC UNCH, UKS FTSE UNCH, ITALYS MIB -0.4.IN ECONOMIC DATA:UKS NOVEMBER INDUSTRIAL PRODUCTION 2.1 MONTH-OVER-MONTH (EXPECTED 0.8 LAST -1.1) 2.0 YEAR-OVER-YEAR (CONSENSUS 0.6 PREVIOUS -0.9). NOVEMBER MANUFACTURING PRODUCTION 1.3 MONTH-OVER-MONTH (EXPECTED 0.5 LAST -1.0) 1.2 YEAR-OVER-YEAR (CONSENSUS 0.4 LAST -0.5). NOVEMBER CONSTRUCTION OUTPUT -0.2 MONTH-OVER-MONTH (EXPECTED 0.3 LAST -0.6) 1.5 YEAR-OVER-YEAR (CONSENSUS 2.0 PREVIOUS 0.7). NOVEMBER TRADE DEFICIT WIDENED TO GBP12.16 BILLION FROM GBP9.89 BILLION (EXPECTED DEFICIT OF GBP11.20 BILLION) SPAINS NOVEMBER INDUSTRIAL PRODUCTION 3.2 YEAR-OVER-YEAR (CONSENSUS 1.0 LAST 0.6)IN NEWS:ALTHOUGH EQUITY MARKETS HAVE MAINTAINED NARROW RANGES SO FAR, THE EURO HAS RETREATED STEADILY, FALLING 0.4 AGAINST THE DOLLAR TO 1.0514. THE DECLINE LEAVES THE SINGLE CURRENCY IN THE BOTTOM HALF OF ITS TRADING RANGE THAT DATES BACK TO EARLY DECEMBER. THE BRITISH POUND HAS ALSO RETREATED AGAINST THE DOLLAR, SURRENDERING 0.5 TO 1.2121, DESPITE ABOVE-CONSENSUS ECONOMIC DATA. ON BALANCE, ECONOMIC DATA RECEIVED SINCE THE BREXIT VOTE HAS BEEN STRONG RELATIVE TO EXPECTATIONS. 8:02 AM REDHILL BIOPHARMA ANNOUNCES THAT RHB-104 HAS BEEN GRANTED QIDP DESIGNATION BY THE FDA FOR THE TREATMENT OF NONTUBERCULOUS MYCOBACTERIA INFECTIONS CO WILL CONSULT WITH THE FDA REGARDING ITS RHB-104 DEVELOPMENT PROGRAM FOR NTM INFECTIONS ( RDHL ). The granted QIDP designation allows RedHill to benefit from Fast-Track status, with an expEDITED DEVELOPMENT PATHWAY FOR RHB-104 FOR THE TREATMENT OF NTM INFECTIONS, AS WELL AS PRIORITY REVIEW, WHICH PROVIDES FOR A SHORTER REVIEW TIME BY THE FDA OF A FUTURE POTENTIAL MARKETING APPLICATION. IF APPROVED FOR THE TREATMENT OF NTM INFECTIONS, RHB-104 WOULD ALSO RECEIVE AN ADDITIONAL FIVE YEARS OF U. S. MARKET EXCLUSIVITY ON TOP OF THE STANDARD EXCLUSIVITY PERIOD. IN LIGHT OF THE QIDP DESIGNATION, REDHILL WILL CONSULT WITH THE FDA REGARDING ITS RHB-104 DEVELOPMENT PROGRAM FOR NTM INFECTIONS. UNDER FDAS GENERATING ANTIBIOTIC INCENTIVES NOW ACT, QIDP DESIGNATION ALLOWS FOR FAST-TRACK STATUS AND PRIORITY REVIEW, POTENTIALLY LEADING TO A SHORTER NDA REVIEW TIME BY THE FDA, AND, IF APPROVED, AN ADDITIONAL FIVE YEARS OF U. S. MARKET EXCLUSIVITY ON TOP OF THE STANDARD EXCLUSIVITY PERIOD. A FIRST PHASE III CLINICAL STUDY WITH RHB-104 FOR THE TREATMENT OF CROHNS DISEASE (THE MAP US STUDY) IS ONGOING IN THE U. S. AND ADDITIONAL COUNTRIES INCREASING EVIDENCE SUPPORTS THE HYPOTHESIS THAT CROHNS DISEASE, AND POTENTIALLY OTHER AUTOIMMUNE DISEASES, ARE RELATED TO MYCOBACTERIUM AVIUM SUBSPECIES PARATUBERCULOSIS (:MAP) INFECTION IN SUSCEPTIBLE PATIENTS. TOP-LINE FINAL RESULTS FROM THE CEASE MS STUDY SUGGEST MEANINGFUL POSITIVE SAFETY AND CLINICAL SIGNALS UPON 24 WEEKS OF TREATMENT WITH RHB-104 AS AN ADD-ON THERAPY, THEREBY SUPPORTING FURTHER CLINICAL DEVELOPMENT. 8:02 AM AMERICAN AIRLINES REPORTS DECEMBER TRAFFIC, RAISES Q4 TRASM, PRE-TAX MARGIN RPMS -0.8 YY ( AAL ) : American Airlines Groups total revenue passenger miles (RPMs) were 18.2 billion, down 0.8 percent versus December 2015. Total capacity was 22.6 billion available seat miles (ASMs), up 0.5 percenT VERSUS DECEMBER 2015. TOTAL PASSENGER LOAD FACTOR WAS 80.6 PERCENT, DOWN 1.0 PERCENTAGE POINT VERSUS DECEMBER 2015. CO EXPECTS Q4 TOTAL REVENUE PER AVAILABLE SEAT MILE (:TRASM) TO BE FLAT TO UP 2 (PRIOR GUIDANCE: -1 TO 1). IN ADDITION, THE COMPANY EXPECTS ITS FOURTH QUARTER PRE-TAX MARGIN EXCLUDING SPECIAL ITEMS TO BE 7-9 (PRIOR GUIDACNE: 6-8) 8:02 AM VIVINT SOLAR CLOSES NEW FINANCING IN TWO SEPARATE TRANSACTIONS A 203 MLN DEBT FACILITY AND A 100 MLN FOLLOW-ON INVESTMENT IN TAX EQUITY FINANCING ( VSLR ). Co closed a fixed-rate, 18-year term debt facility with four insTITUTIONAL INVESTORS, TOTALING 203 MILLION. THE NEW DEBT FACILITY IS A FULLY AMORTIZING LOAN THAT RELIES ON THE CONTRACTUAL CASH FLOWS FROM FOUR EXISTING INVESTMENT FUNDS THAT COMPRISE APPROXIMATELY 214 MEGAWATTS (MWS) AND 30,000 RESIDENTIAL SOLAR SYSTEMS. IN ADDITION, THE COMPANY ALSO ANNOUNCED TODAY THAT IT CLOSED AN INVESTMENT WITH BANK OF AMERICA MERRILL LYNCH, AN EXISTING INVESTOR THAT HAD COMMITTED A 100 MILLION FOLLOW-ON INVESTMENT IN TAX EQUITY FINANCING, WHICH WILL ALLOW THE INSTALLATION OF OVER 66 MWS OF RESIDENTIAL SOLAR ENERGY SYSTEMS. THIS INVESTMENT MARKS THE CLOSING OF A PORTION OF THE TAX EQUITY COMMITMENTS VIVINT SOLAR RECEIVED IN NOVEMBER 2016. 8:01 AM SANDSTORM GOLD ANNOUNCES CO SOLD OVER 13,200 ATTRIBUTABLE GOLD EQUIVALENT OZ DURING THE FOURTH QUARTER OF 2016 amp OVER 49,500 GOLD EQUIVALENT OUNCES FOR THE FULL 2016 YEAR ( SAND ). Co announce that the Company has sold over 13,200 attributable gold equivalent ounces1 during the fourth quarter of 2016 and over 49,500 gold equivalent ounces for the full 2016 year. Both the fOURTH QUARTER AND ANNUAL PRODUCTION RESULTS ARE RECORDS FOR THE COMPANY. THE ATTRIBUTABLE GOLD EQUIVALENT OUNCES WERE GENERATED FROM 21 STREAMS AND ROYALTIES, WITH OVER 70 OF THE OUNCES COMING FROM OPERATIONS RUN BY MAJOR AND MID-TIER MINING COMPANIES. 8:01 AM MYLAN N. V. ANNOUNCES THAT THE FDA HAS ACCEPTED MYLANS BIOLOGICS LICENSE APPLICATION FOR MYL-1401O, A PROPOSED BIOSIMILAR TRASTUZUMAB ( MYL ). Co announces that the FDA has accepted Mylans biologics license application for MYL-1401O, a proposed biosimilar trastuzumab, for filing through the 351 pathway. This product is a proposed biosimilar to branded trastuzumab, which is indicated to treat certain HER2-positive breast cancers. The anticipated FDA goal date set under the Biosimilar User Fee Act is Sept. 3, 2017. 8:00 am On The Wires (:WIRES). Amazon (AMZN) AND CHASE (JPM) INTRODUCED THE NEW AMAZON PRIME REWARDS VISA SIGNATURE CARD, THE ONLY CARD THAT OFFERS 5 BACK ON ALL AMAZON PURCHASES AND REWARDS EVERYWHERE ELSE YOU SHOP, INCLUDING 2 BACK AT RESTAURANTS, GAS STATIONS AND DRUGSTORES, AND 1 BACK ON EVERY OTHER PURCHASE, AVAILABLE EXCLUSIVELY FOR ELIGIBLE PRIME MEMBERS. VIACOM INC. (VIAB) ANNOUNCED THE APPOINTMENT OF DAVID LYNN AS PRESIDENT AND CEO OF VIACOM INTERNATIONAL MEDIA NETWORKS (:VIMN). 7:46 AM KORNIT DIGITAL TO DELIVER A LARGE NUMBER OF TEXTILE PRODUCTION SYSTEMS TO AMAZON ( AMZN ) in support of its Merch by Amazon program co to grant Amazon warrants to acquire over a five-year period up to 2,932,176 of its common shares at 13.03share ( KRNT ) : Through this agreement, Kornit will deliver the companys flagship high-productivity system, the Avalanche 1000, to support Amazons expansion of production capacity for the companys Merch by Amazon service. In conjunction with the commercial agreements, Kornit Digital has agreed to grant Amazon warrants to acquire over a five-year period up to 2,932,176 of Kornit Digitals common shares at 13.03share, based on the volume weighted average closing prices of Kornit Digital common shares for the thirty trading days prior to January 10, 2017. 7:31 am Stellar Biotechnologies to expand production of its Stellar KLH products under a recently established Mexican subsidiary ( SBOT ). 7:31 am TG Therapeutics announces completion of enrollment in part 1 of its phase II study of TG-1101 early data demonstrates rapid and profound B-cell reductions in MS patients treated with TG-1101 with median B-cell reduction of 99 ( TGTX ) : TG-1101 is a novel glycoengineered anti-CD20 monoclonaL ANTIBODY IN PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS. PHASE 3 MS PROGRAM PLANNED TO INITIATE IN 1H 2017. THE PRIMARY OBJECTIVE OF THE STUDY WAS TO ASSESS THE SAFETY AND TOLERABILITY OF TG-1101 IN PATIENTS WITH RMS AS WELL AS TO DETERMINE THE OPTIMAL DOSING REGIMEN FOR TG-1101 BY EXAMINING THE LEVEL OF B-CELL DEPLETION AND THE TOLERABILITY OF ACCELERATED INFUSION TIMES. ESTABLISHED MS CLINICAL EFFICACY ENDPOINTS ARE ALSO BEING EVALUATED, WHICH REQUIRE LONGER-TERM FOLLOW-UP AND ARE ANTICIPATED TO BE REPORTED ON LATER THIS YEAR OR NEXT YEAR AT A MEDICAL CONFERENCE. THE MEDIAN B-CELL DEPLETION FOR ALL PATIENTS IN PART 1 WAS 99 AND TG-1101 WAS WELL-TOLERATED WITH NO GRADE 34 ADVERSE EVENTS REPORTED, INCLUDING IN PATIENTS RECEIVING THE ONE-HOUR INFUSION AT THE TARGET PHASE 3 DOSE AND INFUSION RATE. AS PART 2 OF THE TRIAL, THE COMPANY HAS ADDED EXPANSION COHORTS AND WILL EXPLORE ACCELERATED DOSING OF THE INITIAL 150MG DOSE. quotThe speed at which we were able to rapidly enroll into this study demonstrates the on-going need for new treatment options for patients. We were extremely pleased to see rapid and robust B-cell depletion and excited to see that a one-hour infusion was well tolerated, possibly providing an important convenience advantage over first generation anti-CD20 monoclonal antibodies. We look forward to continuing enrollment into one or more expansion cohorts and to launching a Phase 3 program in the first half of this year. quot 7:30 am Sangamo BioSci confirms that the FDA has granted orphan drug designation to SB-318 for the treatment of Mucopolysaccharidosis Type I ( SGMO ). MPS I is caused by mutations in the gene encoding the alpha-L-iduronidase (:IDUA) enzyme. Using Sangamos zinc finger nuclease (:ZFN) genome editing technology, SB-318 is designed as a single treatment strategy intended to provide stable, continuous production of the IDUA enzyme for the lifetime of the patient. In 2017, Sangamo plans to conduct the first ever in vivo genome editing clinical trials including Phase 12 studies for three lead programs: SB-318 for the treatment of MPS I SB-913 for the treatment of MPS II, another rare lysosomal storage disorder and SB-FIX for the treatment of hemophilia B, a rare blood disease. Data from these studies and from a planned clinical trial for a fourth lead program, SB-525, a gene therapy approach for hemophilia A, are expected in late 2017 or early 2018. 7:29 am On The Wires (:WIRES). Attunity Ltd. (ATTU) announced today that a global, multi-billion dollar insurance company has signed an agreement for 0.8 million in license fees, services and five years of maintenance for Attunity Replicate, which is expected to significantly enhance the performance of the Customers recently implemented data lake analytics solution. Kratos Defense amp Security Solutions (KTOS) announced today that Digital Fusion Solutions, a subsidiary of Kratos Defense amp Rocket Support Services Division, is increasing its support of high energy laser demonstrator development through a task order under its U. S. Army Space and Missile Defense CommandArmy Forces Strategic Command Integrated Test and Analysis Contract Prime Contract. The task is to assist SMDC with High Energy Laser System Engineering, Integration, and Test Support. Kratos support has expanded to include integration and test support at their high bay facility in Huntsville, AL. 7:23 am European Markets Update: DAX 0.4, CAC 0.1, FTSE 0.1 (:SUMRX) : Major European indices trade near their flat lines with Germanys DAX (0.4) showing relative strength while Italys MIB (-0.3) underperforms. Although equity markets have maintained narrow ranges so far, the euro has retreated steadily, falling 0.5 against the dollar to 1.0508. The decline leaves the single currency in the bottom half of its trading range that dates back to early December. The British pound has also retreated against the dollar, surrendering 0.5 to 1.2121, despite above-consensus economic data. On balance, economic data received since the Brexit vote has been strong relative to expectations. In economic data: UKs November Industrial Production 2.1 month-over-month (expected 0.8 last -1.1) 2.0 year-over-year (consensus 0.6 previous -0.9). November Manufacturing Production 1.3 month-over-month (exPECTED 0.5 LAST -1.0) 1.2 YEAR-OVER-YEAR (CONSENSUS 0.4 LAST -0.5). NOVEMBER CONSTRUCTION OUTPUT -0.2 MONTH-OVER-MONTH (EXPECTED 0.3 LAST -0.6) 1.5 YEAR-OVER-YEAR (CONSENSUS 2.0 PREVIOUS 0.7). NOVEMBER TRADE DEFICIT WIDENED TO GBP12.16 BILLION FROM GBP9.89 BILLION (EXPECTED DEFICIT OF GBP11.20 BILLION) SPAINS NOVEMBER INDUSTRIAL PRODUCTION 3.2 YEAR-OVER-YEAR (CONSENSUS 1.0 LAST 0.6) ---EQUITY MARKETS--- GERMANYS DAX IS HIGHER BY 0.4 WITH HEAVYWEIGHTS VOLKSWAGEN, DEUTSCHE BANK, DAIMLER, AND MERCK AMONG THE LEADERS. THE FOUR NAMES ARE UP BETWEEN 1.0 AND 3.7. ON THE DOWNSIDE, SIEMENS AND BMW ARE DOWN 1.0 AND 0.2, RESPECTIVELY. FRANCES CAC HAS ADDED 0.1 AMID RELATIVE STRENGTH IN AUTOMAKERS. PEUGEOT AND RENAULT HOLD RESPECTIVE GAINS OF 3.1 AND 1.0 WHILE MICHELIN HAS ADDED 1.1. FINANCIALS TRADE IN THE RED WITH BNP PARIBAS, SOCIETE GENERALE, AND CREDIT AGRICOLE DOWN BETWEEN 0.4 AND 0.7. UKS FTSE IS HIGHER BY 0.1 THANKS TO GAINS IN CONSUMER NAMES. DIXONS CARPHONE, SAINSBURY, MARKS amp SPENCER, AND UNILEVER SHOW GAINS BETWEEN 0.4 AND 3.6. SELECT FINANCIALS LAG WITH RBS, fx, STANDARD LIFE, AND RSA INSURANCE DOWN BETWEEN 1.0 AND 1.8. ITALYS MIB HAS SHED 0.3. FINANCIALS LIKE BANCO BPM, BANCA POP EMILIA ROMAGNA, UNICREDIT, MEDIOBANCA, INTESA SANPAOLO, AND UBI BANCA ARE DOWN BETWEEN 0.6 AND 2.7. 7:17 AM GLAXOSMITHKLINE EXPECTS THAT THE POSITIVE IMPACT OF FOREIGN EXCHANGE ON FULL YEAR 2016 STERLING CORE EPS WILL BE GREATER THAN THE POSITIVE IMPACT ON SALES ( GSK ). quotAs a result of the mix of currency movements relative to the mix of costs, we expect that the positive impact of foreign exchange on full year 2016 sterling core EPS will be greater than the positive impact on sales. quotquotOver the first nine months of 2016, the benefit of currencies to core EPS was 20 compared with the 8 benefit to sales. quotGSK expects to pay an annual ordinary dividend of 80p for each of the next two years (2016-2017).quotquotIn Respiratory, we continued to transition the portfolio from its previous reliance on AdvairSeretide to a much broader one. Total Respiratory sales were up 8 globally, with double digit growth in the US and International, more than offsetting a 9 decline in Europe. This is primarily the result of growth in the new Ellipta products and Nucala, up 179 million in Sterling terms, which more than offset the 7 decline in AdvairSeretide, which slowed its rate of decline in the quarter. This primarily reflected a mix in the period of better RAR in the US and an improved performance in the emerging markets, offset by continued competitive pressures in Europe. quot 7:02 am Asian Markets Close: Nikkei 0.3, Hang Seng 0.8, Shanghai -0.8 (:SUMRX) : Markets in the Asia-Pacific region ended Wednesday on a mixed note, but the trading day was fairly quiet. The World Bank did lower its GDP growth outlook for 2017 and 2018, but the adjustment only reduced the previous forecast by 10 basis points. The forecast for 2017 was lowered to 2.7 from 2.8. The U. S. growth forecast for 2017 was maintained at 2.2 due to the expected impact of fiscal stimulus under the new administration. In economic data: Japans November Leading Index 102.7 (expected 102.6 previoUS 100.8). NOVEMBER COINCIDENT INDICATOR 1.6 MONTH-OVER-MONTH (LAST 1.0) SOUTH KOREAS DECEMBER UNEMPLOYMENT RATE DECLINED TO 3.4 FROM 3.6. DECEMBER IMPORT PRICE INDEX 9.2 YEAR-OVER-YEAR (LAST 3.6) AND DECEMBER EXPORT PRICE INDEX 6.3 YEAR-OVER-YEAR (LAST 3.5) ---EQUITY MARKETS--- JAPANS NIKKEI ADDED 0.3. GROWTH-SENSITIVE NAMES LIKE SUMCO, NIPPON SHEET GLASS, KOBE STEEL, SUMITOMO METAL MINING, JAPAN STEEL WORKS, MITSUBISHI MATERIALS, AND EBARA POSTED GAINS BETWEEN 2.0 AND 4.4. HONG KONGS HANG SENG CLIMBED 0.8 AMID STRENGTH IN PROPERTY NAMES AND FINANCIALS. SINO LAND, NEW WORLD DEVELOPMENT, HANG LUNG PROPERTIES, CHEUNG KONG PROPERTY HOLDINGS, CHINA OVERSEAS, BANK OF CHINA, PING AN INSURANCE, AND HSBC ADDED BETWEEN 0.8 AND 3.8. CHINA UNICOM HONG KONG LAGGED FOR THE SECOND DAY IN A ROW, FALLING 2.0. CHINAS SHANGHAI COMPOSITE LOST 0.8. SHANG GONG GROUP, TIANJIN GLOBAL MAGNETIC CARD, WUHAN HANSHANG, AND SHEN MA INDUSTRY REGISTERED LOSSES BETWEEN 5.4 AND 6.8. INDIAS SENSEX ADDED 0.9 WITH HELP FROM MOST COMPONENTS. COAL INDIA SPIKED 5.4 WHILE OTHER GROWTH-SENSITIVE NAMES LIKE TATA STEEL, LARSEN amp TOUBRO, POWER GRID, AND MAHINDRAampMAHINDRA RALLIED BETWEEN 1.3 AND 4.0. BAJAJ AUTO WAS THE WEAKEST PERFORMER, FALLING 0.9. ---FX--- USDJPY 0.4 TO 116.24 USDCNY 0.2 TO 6.9341 USDINR UNCH AT 68.350 7:02 AM FORTUNA SILVER MINES ANNOUNCES FY16 TOTAL PRODUCTION OF 7.4 MLN OZ OF SILVER amp 46.6 K OZ OF GOLD ISSUES GUIDANCE FOR FY17 ( FSM ). FY16 production highlights:Silver and gold production were 5 and 9 respectively above 2016 guidance. Silver production of 7,380,217 ounces 11 increase over 2015.Gold production of 46,551 oz 17 increase over 2015.Zinc production of 43,204,154 pounds 21 increase over 2015.Lead production of 32,673,479 pounds 37 increase over 2015.quotIn 2017, our expansion plans are going to be underpinned by our solid low-cost production base providing financial flexibility to execute engineering and development plans for Lindero and continue exploring for new coMPELLING PRECIOUS METAL OPPORTUNITIES IN THE AMERICAS AND ABROAD. quotFY17 guidance:2017 silver equivalent production guidance of 11.2 mln oz.2017 consolidateD AISC OF 9.8OZ AG. 7:01 AM ASANKO GOLD ANNOUNCES PRODUCTION RESULTS FOR THE FOURTH QUARTER OF 2016 GOLD PRODUCTION OF 57,178OZ AND GOLD SALES OF 58,483OZ AGAINST PRODUCTION GUIDANCE OF 52,000 - 57,000OZ ( AKG ) : Commenting on the quarters performance, Peter Breese, President and CEO, said, quotThe operations once again had an impressive quarter with record production of over 57,000 ounces. With the mine now delivering against expectations and the process plant running steadily at 300,000 tonnes per month, or about 20 above design, we enter 2017 with a high performance operating asset that will position us well to finance our Phase 2A expansion project with cash flow from the operations. quot Gold production of 57,178oz and gold sales of 58,483oz against production guidance of 52,000 - 57,000ozUS70.1m in gold revenue at an average realized price of US1,199 per ounce 901,000 tonnes processed during the quarter with a feed grade of 2.15gtIndustry-leading safety record maintained with no LTIs reported during the quarter and a rolling 12 month LTIFR of 0.20. Strong balance sheet with unaudited cash and immediately convertible working capital balances of approximately US66 million (December 31, 2016) 7:01 am Performance Food Group prices 10 mln common stock offering by certain of its stockholders, including affiliates of The Blackstone Group ( BX ) at 22.85share ( PFGC ). 7:01 AM ETHAN ALLEN ISSUES DOWNSIDE PRELIM Q2 RESULTS, WRITTEN RETAIL ORDERS -3.6 ( ETH ) : Co sees Q2 EPS of 0.38-0.39 vs 0.59 Capital IQ Consensus Estimate revs 194.7 mln vs 213.67 mln Capital IQ Consensus Estimate. quotDespite a challenging retail environment during our second quarter ending December 31, 2016 we had a reduction of 3.6 percent in our written retail orders compared to a record written increase of 15.3 percent in the previous year quarter. Due to a delivered sales decline of 6.2 percent, our adjusted operating income is projected to be approximately 8.8 percent of sales compared to 12.2 percent of sales in the previous year quarter. Our adjusted earnings per share is projected to be 0.38- 0.39 compared to 0.55 in the previous year second quarter. quot quotWe are positioned well to benefit from many initiatives including freshening of our offerings, launch of the Ethan AllenDisney collaboration, improvements to our manufacturing and logistics resulting in faster deliveries, relocations and renovations of our design centers, and investments in technology. We are seeing increases in sales from on-line interactions and we expect to see continued increases due to the combination of technology and personal services of our interior designers. Our plans are to start substantially increasing our marketing in both digital and traditional mediums starting from our current third quarter with continued increases as we move forward. quot 7:01 am Upland Software acquires Omtool for 19.2 million (net of cash acquired), expects total revenue and Adjusted EBITDA for the quarter ended December 31, 2016 to be at the upper end of previously-announced guidance ranges. ( UPLD ) : quotQ4 came in strong with continued success in expanding our customer relationships allowing us to affirm our healthy Q4 outlook and to provide record Q1 guidance that reflects both the Omtool acquisition and the continued growth in our core business, quot said Mr. McDonald. quotFinally, we are raising our long term Adjusted EBITDA margin target to 35 to reflect the increased customer loyalty and operating efficiency we are seeing as we scale. quot The purchase price paid for Omtool was 19.2 million (net of cash acquired), within Uplands target range of 5-8x pro forma Adjusted EBITDA. Upland expects the acquisition to generate approximately 11 million in revenue in 2017, subject to reductions for a deferred revenue discount as a result of GAAP purchase accounting. The transaction will be immediately accretive to Uplands Adjusted EBITDA per share. In addition, for the quarter ending March 31, 2017, Upland expects reported total revenue to be in the range of 20.0-20.8 mln including recurring revenue in the range of 17.5 million to 18.1 million vs. the 19.09 mln Capital IQ Consensus. Adjusted EBITDA is expected to be in the range of 5.0 million to 5.5 million, for an Adjusted EBITDA margin of 26 at the mid-point, representing growth of 162 at the mid-point over the quarter ended March 31, 2016.Upland raised its long term Adjusted EBITDA margin target from 30 to 35. 6:59 am On The Wires (:WIRES). Albemarle Corporation (ALB) announced that it intends to redeem all of its outstanding 3.000 Senior Notes due 2019 (CUSIP No. 012725AB3, ISIN NO. US012725AB30) ISSUED BY IT ON FEBRUARY 10, 2017. THE NOTES WILL BE REDEEMED AT A REDEMPTION PRICE EQUAL TO THE GREATER OF (1) 100 OF THE PRINCIPAL AMOUNT OF THE NOTES AND (2) THE SUM OF THE PRESENT VALUES OF THE REMAINING SCHEDULED PAYMENTS OF PRINCIPAL AND INTEREST ON THE NOTES FROM THE REDEMPTION DATE THROUGH THE PAR CALL DATE, AS DEFINED IN THE NOTES, IN EACH CASE DISCOUNTED TO THE DATE OF REDEMPTION ON A SEMI-ANNUAL BASIS AT THE TREASURY RATE PLUS 25 BASIS POINTS, PLUS IN EACH CASE, ACCRUED AND UNPAID INTEREST ON THE NOTES REDEEMED TO, BUT NOT INCLUDING, THE REDEMPTION DATE. CYTODYN INC. (CYDY) ANNOUNCED THE COMPANY FILED A REQUEST FOR BREAKTHROUGH THERAPY DESIGNATION WITH THE FDA FOR PRO 140 AS A TREATMENT FOR HIV-1 INFECTION IN TREATMENT-EXPERIENCED PATIENTS WITH VIROLOGIC FAILURE. BASED ON RESULTS FROM FOUR COMPLETED AND ONGOING CLINICAL TRIALS, THE COMPANY BELIEVES THE PRO 140 TREATMENT OPTION ADDRESSES THE UNMET MEDICAL NEED FOR THERAPY OPTIONS FOR HIV-1 INFECTED PATIENTS WITH UNCONTROLLED VIRAL LOAD, DESPITE CONVENTIONAL ANTIRETROVIRAL THERAPY. WEX (WEX) ANNOUNCED THAT IT HAS SIGNED A NEW AGREEMENT WITH ENTERPRISE FLEET MANAGEMENT IN CANADA. THE PARTNERSHIP SUPPORTS ENTERPRISES GROWTH IN THE CANADIAN MARKET THROUGH WEXS CANADIAN FLEET CAPABILITIES. B COMMUNICATIONS LTD. (BCOM) ANNOUNCED A PRIVATE PLACEMENT OF NIS 118,000,000 PAR VALUE OF ITS SERIES C DEBENTURES TO ISRAELI INSTITUTIONAL INVESTORS FOR AN AGGREGATE CONSIDERATION OF APPROXIMATELY NIS 118 MILLION (APPROXIMATELY US 31 MILLION). 6:58 AM GOLDEN STAR RESOURCES REPORTS Q4 GOLD PRODUCTION OF 53,403 OUNCES GUIDES FOR FY 17 GOLD PRODUCTION OF 255K-280K OZ. 31-44 YY ( GSS ). Gold production of 194,054 ounces in 2016, in the top half of the guidance range of 180,000 to 205,000 ounces Gold production by asset in 2016, as follows: Wassa Main Pit: 93,319 ounces Wassa Underground Gold Mine: 11,062 ounces Prestea Open Pits: 89,673 ouncesWassa Undergrounds mining rates accELERATED STRONGLY DURING THE QUARTER, CULMINATING IN THE DECLARATION OF COMMERCIAL PRODUCTION ON JANUARY 1, 2017 CASH AND CASH EQUIVALENTS BALANCE OF 21.7 MILLION AS OF DECEMBER 31, 2016, WHICH DOES NOT INCLUDE THE RECEIPT OF THE 10 MILLION SCHEDULED ADVANCE PAYMENT ON JANUARY 3, 2017 FROM RGLD GOLD FY 17 GUIDANCE OF: 255,000-280,000 OUNCES OF GOLD PRODUCTION 780-860 PER OUNCE CASH OPERATING COST1 970-1,070 PER OUNCE ALL-IN SUSTAINING COST 6:56 AM THERAPEUTICSMD ANNOUNCES THE PUBLICATION OF 2 MANUSCRIPTS DETAILING RESULTS OF THE PHASE 3 REJOICE TRIAL IN MENOPAUSE: THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY ( TXMD ) : The Rejoice Trial is the pivotal phase 3 study of TX-004HR, an investigational bio-identical 17-estradiol vaginal softgel capsule, for the treatment of moderate-to-severe vaginal pain during sexual intercourse (dyspareunia), a symptom of vulvar vaginal atrophy (:VVA) in postmenopausal women. The manuscripts review the positive results of TX-004HR across all pre-specified primary and secondary endpoints in the Rejoice Trial, as well as data from a pharmacokinetic substudy demonstrating the low systemic absorption of TX-004HR. The FDA has set a Prescription Drug User Fee Act target action date of May 7, 2017 to complete its review of the companys 505(b)(2) NDA submission for TX-004HR. The NDA is supported by the complete TX-004HR clinical program, including positive results of the phase 3 Rejoice Trial, which evaluated the effect of three doses of TX-004HR (4 mcg, 10 mcg and 25 mcg) compared to placebo from baseline to week 12. 6:56 AM SIGNET JEWELERS LOWERS Q4 GUIDANCE HOLIDAY COMPS FELL 4.6 ( SIG ). Lowers Q4 adj. EPS to 4.00-4.05 from 4.00-4.20 vs 4.05 Capital IQ Consensus lowers Q4 comps to (4.3-4.8) from (2-4). Nine week HOLIDAY COMPS FELL 4.6 VS. 5.1 LAST YEAR. MERCHANDISE CATEGORIES AND COLLECTIONS WERE BROADLY LOWER MOST NOTABLY IN THE MALL AND E-COMMERCE SELLING CHANNELS, WHILE SELECT MERCHANDISE AND OTHER SELLING CHANNELS PERFORMED RELATIVELY WELL SUCH AS DIAMOND FASHION JEWELRY, BRACELETS, EARRINGS, EVER US, VERA WANG LOVE, AND THE OFF-MALL AND KIOSK SELLING CHANNELS. SIGNETS E-COMMERCE SALES IN THE HOLIDAY SEASON WERE 142.5 MILLION, DOWN 3.5 MILLION OR 2.4 COMPARED TO 146.0 MILLION IN THE PRIOR YEAR. quotSignets disappointing holiday results were driven principally by underperformance in its Sterling division e-commerce business. A preliminary view of market data suggests that the jewelry category was broadly flat to modestly down with in-store sales down mid-single-digits and e-commerce sales up double-digits. Signets in-store results were in-line with the jewelry market, but technical performance issues in Sterlings e-commerce platform largely led to Signets lower-than-expected results. Sterlings challenges in its e-commerce platform were due to recent enhancements that did not perform as expected when exposed to high holiday volume. We are investing and directing more resources to improve the functioning of the platform and the overall customer digital journey. quotSelect categories, collections, and other selling channels PERFORMED RELATIVELY WELL. quot 6:53 am Gilead Sciences announces the EC has granted marketing authorization for Vemlidy for the treatment of chronic hepatitis B virus infECTION ( GILD ). The marketing authorization allows for the marketing of TAF in the 28 countries of the European UnION, NORWAY, AND ICELAND. 6:50 AM MSC INDUSTRIAL BEATS BY 0.02, REPORTS REVS IN-LINE GUIDES Q2 EPS ABOVE CONSENSUS, REVS IN-LINE ( MSM ). RepORTS Q1 (NOV) EARNINGS OF 0.95 PER SHARE, 0.02 better than the Capital IQ Consensus of 0.93 revenues fell 2.9 yearyear to 686.3 mln vs the 685.46 mln Capital IQ Consensus. Gross margin of 45.0 reflects continued stabilization in a challenging pricing environment. Co issues guidance for Q2, sees EPS of 0.86-0.90 vs. 0.86 Capital IQ Consensus Estimate sees Q2 revs of 688-701 mln vs. 679.02 mln Capital IQ Consensus Estimate. quotWe have operated in the midst of a prolonged industrial recession, one that was particularly acute in our primary end markets of metalworking manufacturing. We are, however, seeing signs of greater optimism. At present, iT APPEARS THAT THERE IS A LEVELING IN MANUFACTURING OCCURRING AND, IN DECEMBER, WE SAW GREATER SPENDING ON CATEGORIES THAT ARE INDICATIVE OF CUSTOMER OPTIMISM. WE ARE CERTAINLY MORE POSITIVE THAN EVEN A FEW SHORT MONTHS AGO. EVEN SO, WE WOULD NEED TO SEE SUSTAINED INCREASES IN ORDER ACTIVITY BEFORE WE DECLARE THAT THE ENVIRONMENT HAS TURNED. quot 6:49 am Asanko Gold appoints Fausto Di Trapani as CFO, effective immediately, following the resignation of Greg McCunn, who has decided to pursue other business opportunities ( AKG ). Di Trapani, a Chartered Accountant, joined Asanko in 2012 as Executive: Finance. 6:47 am Eli Lilly expands collaboration with Merck ( MRK ) to add a new study of Lillys Lartruvo with Keytruda in patients with previously treated advanced or metastatic soft tissue sarcoma ( LLY ). 6:43 AM MAGNA PROVIDES DOWNSIDE GUIDANCE FOR FY 17 REVS OF 30.4-31.7 BLN VS 38 BLN CONSENSUS ESTIMATE ALSO PROVIDES 2019 REVS GUIDANCE OF 43.5-46.2 BLN ( MGA ) : 2017 Guidance Light Vehicle Prouction (Units)North America - 17.7 mlnEurope - 21.7 mlnTotal Production Sales of 30.4-31.7 blnCapital spending of 2 bln 2019 Guidance Light Vehicle Prouction (Units) North America - 18.4 mln Europe - 22.5 mln Total Production Sales of 34.1-36 blnCo states, quotWe believe there is potential for further margin progress by 2019.quot 6:35 am Tenneco sees FY17 revenue growth of 5 (Capital IQ consensus 4.2 over projected FY16) ( TEN ). Co announced that in 2017 the company expects to outpace light vehicle industry production by 4 percentage points, which is at the mid-point of last years estimate for outgrowing the industry in 2017. In total, Tenneco expects year-OVER-YEAR REVENUE GROWTH OF 5. THIS GROWTH ASSUMES CURRENT INDUSTRY PRODUCTION FORECASTS AND IS AT 2016 CONSTANT CURRENCY. quotTenneco has outpaced industry production by more than 3 percentage points over the last 10 years and I am pleased that our revenue outlook for 2017 builds on this proven track record of growth with contributions from both our Clean Air and Ride Performance product lines. quot In 2018 and 2019, Tenneco expects continued revenue growth, outpacing industry production by 3 to 5 percentage points each year. These estimates also exclude the impact of currency. 6:33 am Supervalu misses by 0.09, misses on revs ( SVU ). Reports Q3 (Nov) earnings of 0.05 per share, excluding non-recurring items, 0.09 worse than the Capital IQ Consensus of 0.14 revenues fell 1.4 yearyear to 3 bln vs the 3.76 bln Capital IQ Consensus. Total net sales within the Wholesale segment increased 0.2 percent. Retail identical store sales were negative 5.7 percent. quotThe successful sale of Save-A-Lot early in the fourth quarter provides SUPERVALU with additional flexibility to operate and grow our business, quot said President and CEO MARK GROSS. quotAdditionally, our Wholesale team has done a tremendous job delivering for our customers. It is a significant accomplishment that we increased Wholesale sales compared to last year given the saleS LOST AT THE END OF FISCAL 2016. UNFORTUNATELY, IN OUR RETAIL SEGMENT WE HAVE NOT BEEN ABLE TO OVERCOME PERSISTENT DEFLATION, COMPETITIVE IMPACTS, AND OTHER FACTORS. IT TAKES TIME TO CHANGE CUSTOMERS SHOPPING HABITS, BUT OUR TEAM IS DEDICATED TO IMPROVING OUR RESULTS. quot 6:32 am Borg Warner guides FY17 EPS amp rev below Consensus, guides Q1 EPS in-line projects 5-7 growth from net new biz backlog over the next 3 years ( BWA ). Net new business within a range of 410 mln to 590 mln in 2017, 460 mln to 670 mln in 2018 and 500 mln to 700 mln in 2019.Q1 guidance:Sees EPS of 0.81-0.85 vs. the 0.85 Capital IQ ConsensusOrganic net sales growth of 2.5 to 6.5 compared with first quarter 2016 net sales of 2.27 bln. FY17 guidance:Sees FY17 EPS between 3.35-3.45 vs. the 3.52 Capital IQ Consensus sees revs between 8.81-9.04 bln vs. the 9.31 bln Capital IQ Consensus. Implies organic sales growth of 3.5 to 6.0 compared with expected 2016 net sales of 9.05 bln. Foreign currencies are expected to lower sales by 320 mln, due to the depreciation of the Euro, Yuan and Pound. The sale of the Remy light vehicle aftermarket business IS EXPECTED TO LOWER SALES BY EXCLUDING THE IMPACT OF WEAKER FOREIGN CURRENCIES AND THE REMY LIGHT VEHICLE AFTERMARKET SALE, NET SALES GROWTH IS EXPECTED TO BE 3.5 TO 6.0.SEES FREE CASH FLOW WITHIN A RANGE OF 450 MLN TO 500 MLN. SEES SHARE REPURCHASES OF 100 MLN. 6:30 AM GRAPHIC PACKAGING ANNOUNCES NEW 250 MLN SHARE REPURCHASE PROGRAM ( GPK ). 6:02 am China Digital TV provides a further update on the pending sale of its interests in Beijing Super TV as held by Golden Benefit Technology Limited ( STV ). Pursuant to the previously disclosed Equity Transfer Agreement dated November 7, 2016 and Supplemental Agreement to Equity Transfer Agreement dated December 28, 2016, the Company has received, through its Chinese affiliate, an amount equal to RMB610 million less the previously received deposit, from Changxing Bao Li Rui Xin Technology Co. Super TV has also completed the change of its business registration with the Beijing Administration for Industry and Commerce, as provided in the SA. Pursuant to the SA, the Buyer is required to proceed with the procedures for converting the RMB610 million into US dollars and paying such converted amount to an offshore account designated by Golden Benefit, as soon as possible but in any event no later than September 30, 2017. Until the completion of the currency exchange and payment, the amount is required to be held in the onshore account of the Companys Chinese affiliate. The transaction is expected to close once the Buyer coverts the RMB610 million into US dollars and pays such amount to an offshore account designated by Golden Benefit. 6:01 am Aralez Pharma announces that the USPTO has issued patent covering Yosprala which will expire in late 2032 with possible patent term adjustment into early 2033 ( ARLZ ). 5:58 am On The Wires (:WIRES). LegoChem Biosciences, based in Daejeon South Korea, announced today that the Company has entered into a research licensing agreement with Takeda (TKPYY) to evaluate next-generation antibody drug conjugate candidates. Through this agreement, Takeda will have access to LCBs proprietary ADC technology, ConjuAll. Takeda will have an exclusive option to license global rights for the project results. Clariant, a world leader in specialty chemicals, announced that it is providing total catalyst solutions for two major ammonia production plants in Indonesia, in cooperation with its licensing partner KBR (KBR). The new projects rely on KBRs process technologies combined with a complete range of Clariant catalysts for the entire ammonia production process. EDFs (ECIFY) Energies Nouvelles is announcing the commissioning of four wind farms in the United States with installed capacity totalling over 708 MW. In North America, the Group has also accelerated its solar energy expansion drive in 2016 with notably a new 150 MWac project in the United States. 5:57 am SampP futures vs fair value: 1.30. Nasdaq futures vs fair value: 5.90. 5:57 am European Markets. FTSE. 7291.98. 16.50. 0.20. DAX. 11622.62. 39.30. 0.30. 5:57 am Asian Markets. Nikkei. 19365. 63.20. 0.30. Hang Seng. 22935. 190.50. 0.80. 5:38 am On The Wires (:WIRES). Fujitsu (FJTSY) will from commence sales in Japan of FUJITSU Enterprise Application PLANTIA, an equipment maintenance management system for the manufacturing industry. PLANTIA was developed by Fujitsu Group company Fujitsu Engineering Technologies CytoSorbents (CTSO) and Fresenius Medical Care (FMS) have agreed to broaden the terms of their existing partnership and to add an expansive co-marketing agreement for CytoSorb in countries where the therapy is available today. Syngenta (SYT) has colLABORATED WITH ACCENTURE (ACN) TO DESIGN AND IMPLEMENT A NEW DIGITAL LOGISTICS OPERATING MODEL ACROSS ALL MODES OF TRANSPORTATION, INCLUDING SEA AND AIR FREIGHT GLOBALLY AND ROAD FREIGHT IN NORTH AMERICA AND EUROPE. CITRIX SYSTEMS (CTXS) INTRODUCED GOTOCONFERENCE, A BUSINESS VIDEO CONFERENCING PACKAGE THAT TRANSFORMS ANY ROOM INTO A CONFERENCE ROOM TO HELP TEAMS COLLABORATE. GOTOCONFERENCE COMBINES IN-ROOM HARDWARE WITH GOTOMEETING VIDEO CONFERENCING IN A SINGLE SOLUTION, OFFERING A NEW WAY FOR TEAMS TO INSTANTLY CONDUCT BOTH IMPROMPTU AND SCHEDULED MEETINGS FROM THE CONFERENCE ROOM. 4:39 AM ON THE WIRES (:WIRES). GEMALTO (GTOMY) ANNOUNCED IT IS SUPPLYING BNP PARIBAS (BNPQY) WITH MOBILE PROTECTOR, A HIGHLY SECURE SOLUTION TO PROTECT WA. AN INNOVATIVE MULTI-BRAND, OMNI-CHANNEL MOBILE WALLET THAT COMBINES PAYMENTS, SHOPPING COUPONS AND LOYALTY PROGRAMS. GEMALTOS MOBILE PROTECTOR ENCOMPASSES AN SDK, AND BOTH A CUSTOMER ENROLLMENT AND AN AUTHENTICATION SERVER. EPSON (SEKEY) IS ONCE AGAIN SETTING THE BENCHMARK FOR PROFESSIONAL IMAGING EXCELLENCE WITH THE INTRODUCTION OF THE NEW 17-INCH EPSON SURECOLOR P5000. INCORPORATING THE LATEST IMAGING TECHNOLOGIES, THE SURECOLOR P5000 RESETS THE STANDARD FOR THE DESKTOP PHOTOGRAPHY, FINE ART, GRAPHIC DESIGN, AND PROOFING MARKETS. EQUINIX (EQIX) ANNOUNCED GLOBAL FINANCIAL CLOUD INFRASTRUCTURE PROVIDER, BEEKS FINANCIAL CLOUD, HAS DEPLOYED ON EQUINIXS CLOUD EXCHANGE AS IT CONTINUES TO EXPAND ITS BUSINESS GLOBALLY. TOSHIBA CORPORATIONS (TOSBF) STORAGE amp ELECTRONIC DEVICES SOLUTIONS COMPANY ANNOUNCED THE LAUNCH OF A NEW LINE-UP OF LOW-CAPACITANCE TVS DIODES FOR USE IN HIGH-SPEED INTERFACES IN MOBILE DEVICES, INCLUDING SMARTPHONES, TABLET PCS AND WEARABLE DEVICES. THE NEW DIODES DELIVER THE INDUSTRYS LEADING-CLASS PROTECTION PERFORMANCE. 4:32 AM AIRBUS REPORTS FY16 DELIVERIES ACHIEVING TARGETS ( EADSY ) : Co reports commercial aircraft deliveries in 2016 were up for the14th year in a row, reaching a new company record of 688 aircraft delivered to 82 customers. Deliveries were more than eight percent higher than the previous record of 635 set in 2015.These included 545 single aisle A320 Family of which 68 were A320 neo, 66 A330s, 49 A350 XWBS AND 28 A380S. OVER 40 PERCENT OF SINGLE AISLE DELIVERIES WERE THE LARGER A321 MODELS. AIRBUS ACHIEVED 731 NET ORDERS FROM 51 CUSTOMERS OF WHICH EIGHT ARE NEW. THESE INCLUDED 607 SINGLES AISLE AND 124 WIDE-BODY AIRCRAFT. AT THE END OF 2016, AIRBUS OVERALL BACKLOGSTOOD AT 6,874 AIRCRAFT VALUED AT 1,018 BILLION AT LIST PRICES 4:16 AM PEUGEOT SA REPORTS FY16 UNIT SALES INCREASED BY 5.8, TO 3,146,000 UNITS ( PEUGF ) : CO REPORTS SALES BY THE PSA GROUP INCREASED FOR THE THIRD CONSECUTIVE YEAR IN 2016, SALES INCREASED BY 5.8, TO 3,146,000 UNITS THE PRODUCT OFFENSIVE IN THE PUSH TO PASS PLAN WAS LAUNCHED FOR THE PEUGEOT AND CITRON BRANDS. SUCCESSFUL COMMERCIAL LAUNCHES FOR THE NEW PEUGEOT 3008 SUV, EXPERT AND TRAVELLER, THE NEW CITRON C3, THE NEW JUMPY AND SPACETOURER. 3:20 AM ALBEMARLE PRICES OFFERINGS OF 250 MLN OF 3.000 NOTES DUE 2019 AND 350 MLN OF 4.500 NOTES DUE 2020 ( ALB ). 3:19 am Parsley Energy upsizes offering by 2 mln shares and prices 22 mln shares of common stock for total proceeds of 770 mln ( PE ). 3:17 am Integra releases Q4 and FY17 guidance sees Q4 and FY17 EPS in-line with consensus ( IART ). Co issues guidance for Q4 (Dec), sees EPS of 0.50-0.53 vs. 0.52 Capital IQ Consensus Estimate sees Q4 (Dec) revs of 256 mln vs. 263.11 mln Capital IQ Consensus Estimate (resulting in full-year 2016 revenue of 992 million, at the low end of the previously provided guidance range)Co issues guidance for FY17 (Dec), sees EPS of 1.91-1.97 vs. 1.96 Capital IQ Consensus Estimate sees FY17 (Dec) revs of 1.05-1.07 bln vs. 1.07 bln Capital IQ Consensus Estimate. 2017 Financial Guidance This preliminary 2017 guidance does not include the acquisition of Derma Sciences ( DSCI ) which has not closed. Unter der Annahme eines Abschlusstermins zum Ende des ersten Quartals 2017 erwartet Integra eine Akquisition von 65 Millionen Umsatzerlösen und eine Verwässerung des bereinigten Ergebnisses je Aktie um rund drei Cent im Jahr 2017. Die Akquisition wird voraussichtlich zu einem bereinigten Ergebnis führen Im Jahr 2018 und bis zum Ende des dritten Jahres unsere Rendite auf die investierte Kapitalhürde zu erreichen. 3:08 am Derma Sciences to be acquired by Integra LifeSciences ( IART ) for 7.00 per share ( DSCI ) : Derma Sciences ( DSCI ) announced that it has signed a definitive agreement whereby Derma Sciences will be acquired by Integra LifeSciences ( IART ) for 7.00 per share of common stock in cash, or a total of 204 million, and 32.00 per share for its outstanding shares of Series A Convertible Preferred Stock and 48.00 per share for its Series B Convertible Preferred Stock, reflecting the stated value of such preferred stock in each case. Der Kaufpreis spiegelt eine 40 Prämie zum Aktienkurs am Markt am 10. Januar 2017 und eine 45 Prämie zum 30-tägigen volumengewichteten durchschnittlichen Aktienkurs von 4,83 wider. Integra wird auch die Eventualverbindlichkeiten im Zusammenhang mit der BioD-Transaktion übernehmen, einschließlich der Produktregulierungsmeilensteinzahlung sowie der Wachstumsauszahlungen für 2017 und 2018. The transaction, which has been approved by the boards of directors of both companies, is expected to close in the first quarter of 2017. The combination: Expands Integras regenerative technology capabilities and accelerates its advanced wound care strategy with the addition of amniotic tissue-based products Leverages its existing sales channel with the addition of a complementary line of advanced wound care products 3:06 am On The Wires (:WIRES). Southern California Gas Company, subsidiary of Sempra Energy (SRE), announced the company will be one of the first natural gas utilities in the United States to incorporate innovative fiber optic cable technology to detect impacts and leaks along its transmission and high-pressure pipeline system. Apptio (APTI) introduced the next generation of its Bill of IT application. With it, IT leaders can now showcase the services provided to their business partners and demonstrate their value across both traditional and cloud-only environments. 3:05 am Hospitality Props prices offerings of 200 mln of 4.50 unsecured senior notes due 2023 and 400 mln of 4.95 unsecured senior notes due 2027 ( HPT ).
No comments:
Post a Comment